0	Human CC chemokine liver-expressed chemokine/CCL16 is a functional ligand for PROTEIN , PROTEIN1PROTEIN2 , PROTEIN and PROTEIN , and constitutively expressed by hepatocytes .
0	Deletion of the complete active-site [ des- ( 161-228 ) -MMP-1 ] within the catalytic domain , or mutation of a single His residue of the Zn2+ binding domain ( His199 ) , generates stable forms of PROTEIN proteins which are unable to digest PROTEIN1 or PROTEIN2 .
0	Evidence for a differential interaction of PROTEIN and the insulin receptor substrate-1 ( PROTEIN ) with the insulin-like growth factor-I ( PROTEIN1PROTEIN2 ) with the insulin-like growth factor-I ( PROTEIN ) receptor in the yeast two-hybrid system .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN1PROTEIN2 , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	PROTEIN associates with the platelet-derived growth factor ( PROTEIN1PROTEIN2 after ligand stimulation , and binding of PROTEIN to this receptor promotes tyrosine phosphorylation of PROTEIN .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN1PROTEIN2 is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN1 or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN ) to be activated by PROTEIN , PROTEIN , and PROTEIN2 .
0	Deletion analysis and binding studies demonstrate that a third enzyme , protein kinase C ( PROTEIN ) , binds PROTEIN1 at a site distinct from those bound by PROTEIN or PROTEIN2 .
1	Taken together , PROTEIN1 is a new low-affinity functional ligand for PROTEIN , PROTEIN2 and PROTEIN , and is constitutively expressed by liver parenchymal cells .
0	A new cytokine-receptor binding mode revealed by the crystal structure of the PROTEIN1PROTEIN2 with an antagonist .
0	While injection of PROTEIN or PROTEIN proteins alone into quiescent rat fibroblasts did not have mitogenic effect , microinjection of PROTEIN together with PROTEIN1PROTEIN2 together with PROTEIN protein stimulated DNA synthesis .
1	Activation of PROTEIN1 by PROTEIN2 in NIH 3T3 cells and in vitro .
0	In this recombinant expression system , the PROTEIN relatives , human PROTEIN related protein ( PROTEIN1 or PROTEIN ) and the PROTEIN2 from Torpedo electric organ , also bind to translated beta 1-syntrophin .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN1PROTEIN2 , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	PROTEIN1 associates with the platelet-derived growth factor ( PROTEIN ) receptor after ligand stimulation , and binding of PROTEIN2 to this receptor promotes tyrosine phosphorylation of PROTEIN .
0	These cell lines showed mutations in PROTEIN1 and PROTEIN2 at frequencies of 91 % and 95 % , respectively .
0	Deletion of the complete active-site [ des- ( 161-228 ) -MMP-1 ] within the catalytic domain , or mutation of a single His residue of the Zn2+ binding domain ( His199 ) , generates stable forms of PROTEIN1 proteins which are unable to digest PROTEIN2 or PROTEIN .
1	Rather , the hydrophobic amino acid residues Leu-22 and Trp-23 of human PROTEIN1 are both required for trans-activation activity , binding to the adenovirus PROTEIN2 55-kD protein and the human mdm-2-p53 protein in vitro .
0	Residues in human leukemia inhibitory factor ( PROTEIN1PROTEIN2 ( PROTEIN ) crucial for binding to both the human PROTEIN receptor ( R ) and PROTEIN were identified by analysis of alanine scanning mutants of PROTEIN in assays for both receptor binding and bioactivity .
0	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN ) to be activated by PROTEIN1 , PROTEIN2 , and PROTEIN .
0	Identification of a critical ligand binding determinant of the human PROTEIN1PROTEIN2 .
0	Three naturally occurring ligands for the PROTEIN1 ( PROTEIN ) exist : the agonists PROTEIN and PROTEIN and the PROTEIN2-receptor antagonist PROTEIN ( ref .
0	We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate , namely interleukin ( IL ) -8 , PROTEIN1PROTEIN2 , PROTEIN and PROTEIN versus PROTEIN .
0	We propose that ( i ) the PROTEIN and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates , PROTEIN and PROTEIN , and ( ii ) PROTEIN1PROTEIN2 share at least in part the same molecular mechanism underlying their interplay with their two substrates , PROTEIN and PROTEIN , and ( ii ) PROTEIN interacts with the PROTEIN in a fashion that is different from that used by PROTEIN .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN1PROTEIN2 in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN1PROTEIN2 , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	Three naturally occurring ligands for the PROTEIN receptor ( PROTEIN ) exist : the agonists PROTEIN and PROTEIN1PROTEIN2 and PROTEIN and the PROTEIN antagonist PROTEIN ( ref .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN1PROTEIN2 binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
1	The acidic amino terminus of the PROTEIN1 protein has been shown to contain this trans-activation activity as well as the domains for PROTEIN2 and adenovirus 5 PROTEIN 55-kD protein binding .
1	We have found a COOH-terminal 37-kD fragment of beta 1-syntrophin sufficient to interact with translated PROTEIN and its homologues , suggesting that the PROTEIN1 binding site on PROTEIN2 occurs on a region that is conserved among the three syntrophin homologues .
0	We have cloned cDNAs corresponding to the human interleukin 13 receptor alpha chain ( PROTEIN1PROTEIN2 receptor alpha chain ( PROTEIN ) .
0	Neither mutation of His199 , nor deletion mutants des- ( 161-228 ) -MMP-1 and des- ( 161-228/248-450 ) -MMP-1 , interact with PROTEIN1PROTEIN2 , interact with PROTEIN .
0	The most typical mutational profile involved PROTEIN , PROTEIN1 , and PROTEIN2 , concurrently aberrated in 20 cases ( 91 % ) .
1	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the insulin-like growth factor-I receptor ( PROTEIN ) and the insulin receptor ( PROTEIN1 ) with their two known substrates PROTEIN and the PROTEIN2 ( PROTEIN ) .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN1PROTEIN2 in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN1PROTEIN2 in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN1PROTEIN2 in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	Analysis of PROTEIN1 , PROTEIN , PROTEIN2 and DPC4/Smad4 .
0	PROTEIN associates with the platelet-derived growth factor ( PROTEIN1 ) receptor after ligand stimulation , and binding of PROTEIN to this receptor promotes tyrosine phosphorylation of PROTEIN2 .
0	The subcellular distributions of PROTEIN1 and PROTEIN2 were similar in neurons .
0	The PROTEIN proteins purified from cells infected with EC12 or 22W viruses activated PROTEIN1PROTEIN2 from skeletal muscle in vitro .
1	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the insulin-like growth factor-I receptor ( PROTEIN ) and the PROTEIN1 ( PROTEIN ) with their two known substrates PROTEIN and the insulin receptor substrate-1 ( PROTEIN2 ) .
0	cDNA cloning and characterization of the human PROTEIN1PROTEIN2 .
1	Several hydrophobic amino acids in the PROTEIN1 amino-terminal domain are required for transcriptional activation , binding to PROTEIN2 and the adenovirus 5 PROTEIN 55-kD protein .
0	MAIN OUTCOME MEASURES : Measurement of soluble interleukin ( IL ) 2 receptor ( PROTEIN1PROTEIN2 ( PROTEIN ) and PROTEIN in serum samples and fluid of recent blisters .
0	Evidence for a differential interaction of PROTEIN and the insulin receptor substrate-1 ( PROTEIN ) with the insulin-like growth factor-I ( PROTEIN1PROTEIN2 and the insulin receptor substrate-1 ( PROTEIN ) with the insulin-like growth factor-I ( PROTEIN ) receptor in the yeast two-hybrid system .
1	This work shows that single and double Ala substitutions of His18 and Phe21 in PROTEIN reduced up to 77-fold the binding affinity to PROTEIN1 receptor subtypes A ( PROTEIN ) and B ( PROTEIN2 ) and to the Duffy antigen .
0	The PROTEIN1 protein shares no significant homology with PROTEIN2 or other PROTEIN family proteins , which can form homo- and heterodimers .
0	The most typical mutational profile involved PROTEIN1 , PROTEIN2 , and PROTEIN , concurrently aberrated in 20 cases ( 91 % ) .
1	The catalytic domain of activated collagenase I ( PROTEIN1 ) is absolutely required for interaction with its specific inhibitor , tissue inhibitor of metalloproteinases-1 ( PROTEIN2 ) .
0	No significant differences were found in serum samples of patients with TEN and burns , in either PROTEIN1 or PROTEIN2 .
1	Human PROTEIN1/CCL16 is a functional ligand for PROTEIN , PROTEIN and PROTEIN2 , and constitutively expressed by hepatocytes .
0	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN1 and the epithelial splice form of PROTEIN2 ( PROTEIN ) to be activated by PROTEIN , PROTEIN , and PROTEIN .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN1PROTEIN2 in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	Residues in human PROTEIN1 ( PROTEIN ) crucial for binding to both the human PROTEIN receptor ( R ) and PROTEIN were identified by analysis of alanine scanning mutants of PROTEIN2 in assays for both receptor binding and bioactivity .
0	The PROTEIN1 , PROTEIN2 , PROTEIN and PROTEIN genes are among those most frequently altered in pancreatic ductal carcinoma .
0	Inflammation , regardless of whether it is provoked by infection or by tissue damage , starts with the activation of macrophages which initiate a cascade of inflammatory responses by producing the cytokines PROTEIN1 ( PROTEIN ) and PROTEIN2 ( ref .
0	MATERIALS AND METHODS : We measured levels of PROTEIN , PROTEIN1 , PROTEIN2 and PROTEIN in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay .
0	Three naturally occurring ligands for the PROTEIN receptor ( PROTEIN ) exist : the agonists PROTEIN and PROTEIN and the PROTEIN1PROTEIN2 ) exist : the agonists PROTEIN and PROTEIN and the PROTEIN antagonist PROTEIN ( ref .
0	In summary , we have shown that the integrity of the catalytic domain of PROTEIN1 and its ability to bind Zn2+ is absolutely required for complex formation with PROTEIN , which further underlines the importance of this region for proper regulation of enzymatic activity of PROTEIN2 .
0	Activation of PROTEIN1 kinase by PROTEIN2 in NIH 3T3 cells and in vitro .
0	We have found a COOH-terminal 37-kD fragment of beta 1-syntrophin sufficient to interact with translated PROTEIN1 and its homologues , suggesting that the PROTEIN2 binding site on beta 1-syntrophin occurs on a region that is conserved among the three syntrophin homologues .
1	Here we describe the crystal structure at 2.7 A resolution of the soluble extracellular part of PROTEIN1 complexed with PROTEIN2 .
1	We have found a COOH-terminal 37-kD fragment of PROTEIN1 sufficient to interact with translated PROTEIN2 and its homologues , suggesting that the PROTEIN binding site on beta 1-syntrophin occurs on a region that is conserved among the three syntrophin homologues .
1	Human CC chemokine liver-expressed chemokine/PROTEIN1 is a functional ligand for PROTEIN , PROTEIN2 and PROTEIN , and constitutively expressed by hepatocytes .
0	Activation of PROTEIN1 results in rapid , site-specific dephosphorylation of PROTEIN at one or more of these three sites and is coincident with increased PROTEIN2-binding activity .
0	In this recombinant expression system , the PROTEIN relatives , human PROTEIN1 ( PROTEIN or PROTEIN ) and the PROTEIN2 from Torpedo electric organ , also bind to translated beta 1-syntrophin .
0	Only weak PROTEIN binding activity was found in cells transfected with only PROTEIN ; however , the combination of both PROTEIN and PROTEIN1 resulted in substantial binding activity , with a Kd of approximately 400 pM , indicating that both chains are essential components of the PROTEIN2 .
1	Three naturally occurring ligands for the PROTEIN receptor ( PROTEIN1 ) exist : the agonists PROTEIN and PROTEIN2 and the PROTEIN antagonist PROTEIN ( ref .
0	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN1 or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN2 ) to be activated by PROTEIN , PROTEIN , and PROTEIN .
0	Three naturally occurring ligands for the PROTEIN receptor ( PROTEIN ) exist : the agonists PROTEIN and PROTEIN and the PROTEIN1 PROTEIN2 ( ref .
0	Whereas PROTEIN1 serves as an alternative accessory protein to the common cytokine receptor gamma chain ( PROTEIN2 ) for IL-4 signaling , it could not replace the function of PROTEIN in allowing enhanced PROTEIN binding activity .
1	We demonstrate that the 53 amino acids encoded on exon 74 of PROTEIN1 , an alternatively spliced exon , are necessary and sufficient for interaction with translated PROTEIN2 in our assay .
0	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN1 ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN2 ) to be activated by PROTEIN , PROTEIN , and PROTEIN .
0	Deletion of the complete active-site [ des- ( 161-228 ) -MMP-1 ] within the catalytic domain , or mutation of a single His residue of the Zn2+ binding domain ( His199 ) , generates stable forms of PROTEIN1 proteins which are unable to digest collagen type I or PROTEIN2 .
0	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the insulin-like growth factor-I receptor ( PROTEIN1 ) and the insulin receptor ( PROTEIN ) with their two known substrates PROTEIN and the PROTEIN2 substrate-1 ( PROTEIN ) .
0	Activation of PROTEIN1PROTEIN2 by PROTEIN in NIH 3T3 cells and in vitro .
0	We propose that ( i ) the PROTEIN and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates , PROTEIN and PROTEIN , and ( ii ) PROTEIN interacts with the PROTEIN1PROTEIN2 and PROTEIN , and ( ii ) PROTEIN interacts with the PROTEIN in a fashion that is different from that used by PROTEIN .
0	In this recombinant expression system , the PROTEIN1 relatives , human PROTEIN related protein ( PROTEIN2 or PROTEIN ) and the 87K postsynaptic protein from Torpedo electric organ , also bind to translated beta 1-syntrophin .
0	Evidence for a differential interaction of PROTEIN and the insulin receptor substrate-1 ( PROTEIN ) with the insulin-like growth factor-I ( PROTEIN1PROTEIN2 ( PROTEIN ) with the insulin-like growth factor-I ( PROTEIN ) receptor in the yeast two-hybrid system .
0	This study describes the distributions of bone morphogenetic protein ( BMP ) -2 as well as mRNAs for BMP receptor type IB ( PROTEIN1PROTEIN2 as well as mRNAs for BMP receptor type IB ( PROTEIN ) .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN1PROTEIN2 and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	Three naturally occurring ligands for the PROTEIN1 ( PROTEIN ) exist : the agonists PROTEIN and PROTEIN and the PROTEIN antagonist PROTEIN2 ( ref .
0	The PROTEIN , PROTEIN , PROTEIN1 and PROTEIN2 genes are among those most frequently altered in pancreatic ductal carcinoma .
0	In this recombinant expression system , the PROTEIN1 relatives , human PROTEIN2 ( PROTEIN or PROTEIN ) and the 87K postsynaptic protein from Torpedo electric organ , also bind to translated beta 1-syntrophin .
1	We propose that ( i ) the PROTEIN1 and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates , PROTEIN and PROTEIN2 , and ( ii ) PROTEIN interacts with the PROTEIN in a fashion that is different from that used by PROTEIN .
0	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the PROTEIN1 receptor ( PROTEIN ) and the insulin receptor ( PROTEIN ) with their two known substrates PROTEIN and the insulin receptor substrate-1 ( PROTEIN2 ) .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN1PROTEIN2 bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	The PROTEIN1 ( PROTEIN2 ) is a member of a family of cytokine and growth factor receptors that share conserved features in their extracellular and cytoplasmic domains .
0	A cDNA clone encoding a novel , widely expressed protein ( called growth factor receptor-bound protein 2 or PROTEIN1PROTEIN2 or PROTEIN ) containing one src homology 2 ( SH2 ) domain and two SH3 domains was isolated .
0	The catalytic domain of activated PROTEIN1 ( PROTEIN2 ) is absolutely required for interaction with its specific inhibitor , tissue inhibitor of metalloproteinases-1 ( PROTEIN ) .
0	Three naturally occurring ligands for the PROTEIN receptor ( PROTEIN1 ) exist : the agonists PROTEIN2 and PROTEIN and the PROTEIN antagonist PROTEIN ( ref .
0	Here , we describe the production of recombinant human tissue inhibitor of metalloproteinases-1 ( PROTEIN1 ) and wild-type and mutant human PROTEIN2 ( PROTEIN ) proteins in SF9 cells by the baculovirus expression system .
1	This suggests that PROTEIN1 must interact with PROTEIN2 throughout most of its folding reaction before it acquires a folding competent ( groE independent ) state .
0	These very same hydrophobic residues contact the PROTEIN and Ad5 PROTEIN1PROTEIN2 and Ad5 PROTEIN 55-kD oncogene products .
0	The PROTEIN , PROTEIN1 , PROTEIN2 and PROTEIN genes are among those most frequently altered in pancreatic ductal carcinoma .
0	Wild-type PROTEIN1 , as well as the PROTEIN mutant lacking the C-terminal hemopexin-like domain [ des- ( 248-450 ) -MMP-1 ] , exhibit enzymatic activity upon cleavage of the prodomain by treatment with PROTEIN2 or 4-aminophenylmercuric acetate .
0	We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate , namely PROTEIN1 , PROTEIN and PROTEIN2 versus PROTEIN .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN1PROTEIN2 in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	PROTEIN1 was detected in mesenchymal cells in the outer fibrous layer and chondrocytes in the inner cartilaginous matrix , positive for Col III and PROTEIN2 , respectively .
0	Rather , the hydrophobic amino acid residues Leu-22 and Trp-23 of human PROTEIN1 are both required for trans-activation activity , binding to the adenovirus PROTEIN 55-kD protein and the human mdm-2-PROTEIN2 protein in vitro .
0	Three naturally occurring ligands for the PROTEIN1 receptor ( PROTEIN ) exist : the agonists PROTEIN2 and PROTEIN and the PROTEIN antagonist PROTEIN ( ref .
0	We have probed an epitope sequence ( His18-Pro19-Lys20-Phe21 ) in PROTEIN ( PROTEIN1PROTEIN2 ( PROTEIN ) by site-directed mutagenesis .
0	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN1 or PROTEIN and the epithelial splice form of PROTEIN2 ( PROTEIN ) to be activated by PROTEIN , PROTEIN , and PROTEIN .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN1PROTEIN2 and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN1PROTEIN2 and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	Evidence for a differential interaction of PROTEIN1 and the insulin receptor substrate-1 ( PROTEIN2 ) with the insulin-like growth factor-I ( PROTEIN ) receptor in the yeast two-hybrid system .
0	PROTEIN was detected in mesenchymal cells in the outer fibrous layer and chondrocytes in the inner cartilaginous matrix , positive for PROTEIN1 and PROTEIN2 , respectively .
1	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the insulin-like growth factor-I receptor ( PROTEIN ) and the PROTEIN1 ( PROTEIN ) with their two known substrates PROTEIN and the PROTEIN2 ( PROTEIN ) .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN1PROTEIN2 binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
1	By rational mutagenesis , receptor-specific functional analysis , and visualization of complex formation in solution , we identified individual amino acid side chains involved specifically in the interaction of ciliary neurotrophic factor ( PROTEIN1 ) with PROTEIN2 and not with the beta-components , PROTEIN and PROTEIN .
1	At relatively high concentrations , PROTEIN1 induced calcium mobilization and chemotaxis via PROTEIN2 and PROTEIN .
0	Deletion analysis and binding studies demonstrate that a third enzyme , protein kinase C ( PROTEIN1 ) , binds PROTEIN at a site distinct from those bound by PROTEIN or PROTEIN2 .
0	Similarly , in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase ( PROTEIN1 ) and phosphatase 2B [ PROTEIN ( PROTEIN ) ] are complexed by an A kinase anchoring protein , PROTEIN2 .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN1PROTEIN2 , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	Similarly , in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase ( PROTEIN ) and phosphatase 2B [ PROTEIN ( PROTEIN ) ] are complexed by an PROTEIN1 , PROTEIN2 .
0	Only weak PROTEIN binding activity was found in cells transfected with only PROTEIN ; however , the combination of both PROTEIN1 and PROTEIN resulted in substantial binding activity , with a Kd of approximately 400 pM , indicating that both chains are essential components of the PROTEIN2 .
0	In this recombinant expression system , the PROTEIN relatives , human PROTEIN1PROTEIN2 ( PROTEIN or PROTEIN ) and the 87K postsynaptic protein from Torpedo electric organ , also bind to translated beta 1-syntrophin .
0	Deletion of the complete active-site [ des- ( 161-228 ) -PROTEIN1 ] within the catalytic domain , or mutation of a single His residue of the Zn2+ binding domain ( His199 ) , generates stable forms of PROTEIN2 proteins which are unable to digest collagen type I or PROTEIN .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN1PROTEIN2 and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	This work shows that single and double Ala substitutions of His18 and Phe21 in PROTEIN reduced up to 77-fold the binding affinity to PROTEIN1 ( PROTEIN ) and B ( PROTEIN2 ) and to the Duffy antigen .
1	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN1 binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN2 , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	Analysis of PROTEIN1 , PROTEIN2 , PROTEIN and DPC4/Smad4 .
1	Human CC chemokine liver-expressed chemokine/PROTEIN1 is a functional ligand for PROTEIN2 , PROTEIN and PROTEIN , and constitutively expressed by hepatocytes .
0	PROTEIN associates with the PROTEIN1 after ligand stimulation , and binding of PROTEIN to this receptor promotes tyrosine phosphorylation of PROTEIN2 .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN1PROTEIN2 is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
1	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN1 ) to be activated by PROTEIN , PROTEIN , and PROTEIN2 .
0	Deletion analysis and binding studies demonstrate that a third enzyme , protein kinase C ( PROTEIN1PROTEIN2 ( PROTEIN ) , binds PROTEIN at a site distinct from those bound by PROTEIN or PROTEIN .
0	Activation of protein kinase C results in rapid , site-specific dephosphorylation of PROTEIN1 at one or more of these three sites and is coincident with increased PROTEIN2-binding activity .
0	In gene transfer experiments using a human lymphoid cell line , Jurkat , coexpression of PROTEIN1 and PROTEIN provided markedly increased protection from cell death induced by several stimuli , including staurosporine , anti-Fas antibody , and cytolytic T cells , relative to cells that contained gene transfer-mediated elevations in either PROTEIN2 or PROTEIN protein alone .
0	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the PROTEIN1 ( PROTEIN ) and the insulin receptor ( PROTEIN2 ) with their two known substrates PROTEIN and the insulin receptor substrate-1 ( PROTEIN ) .
0	Cloning and functional analysis of PROTEIN : a novel PROTEIN1PROTEIN2-binding protein with anti-cell death activity .
0	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN ) to be activated by PROTEIN , PROTEIN1PROTEIN2 ( PROTEIN ) to be activated by PROTEIN , PROTEIN , and PROTEIN .
0	Soluble interleukin 2 receptor and PROTEIN1PROTEIN2 and interleukin 1alpha in toxic epidermal necrolysis : a comparative analysis of serum and blister fluid samples .
0	Several hydrophobic amino acids in the PROTEIN amino-terminal domain are required for transcriptional activation , binding to PROTEIN1 and the adenovirus PROTEIN2 55-kD protein .
0	Deletion analysis and binding studies demonstrate that a third enzyme , protein kinase C ( PROTEIN ) , binds PROTEIN at a site distinct from those bound by PROTEIN or PROTEIN1PROTEIN2 ( PROTEIN ) , binds PROTEIN at a site distinct from those bound by PROTEIN or PROTEIN .
0	We propose that ( i ) the PROTEIN and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates , PROTEIN and PROTEIN , and ( ii ) PROTEIN interacts with the PROTEIN in a fashion that is different from that used by PROTEIN1PROTEIN2 share at least in part the same molecular mechanism underlying their interplay with their two substrates , PROTEIN and PROTEIN , and ( ii ) PROTEIN interacts with the PROTEIN in a fashion that is different from that used by PROTEIN .
0	Evidence for a differential interaction of PROTEIN and the insulin receptor substrate-1 ( PROTEIN1PROTEIN2 ( PROTEIN ) with the insulin-like growth factor-I ( PROTEIN ) receptor in the yeast two-hybrid system .
0	Only weak PROTEIN binding activity was found in cells transfected with only PROTEIN ; however , the combination of both PROTEIN and PROTEIN1 resulted in substantial binding activity , with a Kd of approximately 400 pM , indicating that both chains are essential components of the PROTEIN2 receptor .
0	Whereas PROTEIN1 serves as an alternative accessory protein to the common cytokine receptor gamma chain ( PROTEIN ) for IL-4 signaling , it could not replace the function of PROTEIN2 in allowing enhanced PROTEIN binding activity .
0	Here we describe the crystal structure at 2.7 A resolution of the soluble extracellular part of type-I PROTEIN1PROTEIN2 complexed with PROTEIN .
0	By rational mutagenesis , receptor-specific functional analysis , and visualization of complex formation in solution , we identified individual amino acid side chains involved specifically in the interaction of ciliary neurotrophic factor ( PROTEIN ) with CNTFR alpha and not with the beta-components , PROTEIN1PROTEIN2 and not with the beta-components , PROTEIN and PROTEIN .
0	The acidic amino terminus of the PROTEIN protein has been shown to contain this trans-activation activity as well as the domains for PROTEIN1 and adenovirus 5 PROTEIN2 55-kD protein binding .
0	Similarly , in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase ( PROTEIN1 ) and PROTEIN2 [ PROTEIN ( PROTEIN ) ] are complexed by an A kinase anchoring protein , PROTEIN .
0	Similarly , in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase ( PROTEIN ) and phosphatase 2B [ PROTEIN ( PROTEIN1 ) ] are complexed by an A kinase anchoring protein , PROTEIN2 .
0	Taken together , PROTEIN is a new low-affinity functional ligand for PROTEIN , PROTEIN and PROTEIN1PROTEIN2 , PROTEIN and PROTEIN , and is constitutively expressed by liver parenchymal cells .
0	Here , we describe the production of recombinant human tissue inhibitor of metalloproteinases-1 ( PROTEIN ) and wild-type and mutant human PROTEIN1 ( PROTEIN2 ) proteins in SF9 cells by the baculovirus expression system .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN1PROTEIN2 is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	The most typical mutational profile involved PROTEIN1 , PROTEIN , and PROTEIN2 , concurrently aberrated in 20 cases ( 91 % ) .
1	We propose that ( i ) the PROTEIN and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates , PROTEIN and PROTEIN , and ( ii ) PROTEIN interacts with the PROTEIN1 in a fashion that is different from that used by PROTEIN2 .
0	PROTEIN1 ( PROTEIN ) /PROTEIN2 is a human CC chemokine selectively expressed in the liver .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN1PROTEIN2 , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN1PROTEIN2 and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	PROTEIN associates with the PROTEIN1 ( PROTEIN ) receptor after ligand stimulation , and binding of PROTEIN to this receptor promotes tyrosine phosphorylation of PROTEIN2 .
0	Evidence for a differential interaction of PROTEIN and the insulin receptor substrate-1 ( PROTEIN ) with the PROTEIN1PROTEIN2 and the insulin receptor substrate-1 ( PROTEIN ) with the insulin-like growth factor-I ( PROTEIN ) receptor in the yeast two-hybrid system .
0	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the PROTEIN1 ( PROTEIN ) and the insulin receptor ( PROTEIN ) with their two known substrates PROTEIN and the PROTEIN2 substrate-1 ( PROTEIN ) .
0	This work shows that single and double Ala substitutions of His18 and Phe21 in PROTEIN reduced up to 77-fold the binding affinity to PROTEIN1 ( PROTEIN2 ) and B ( PROTEIN ) and to the Duffy antigen .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN1PROTEIN2 , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN1PROTEIN2 bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
1	Human PROTEIN1/CCL16 is a functional ligand for PROTEIN , PROTEIN2 and PROTEIN , and constitutively expressed by hepatocytes .
0	We have found a COOH-terminal 37-kD fragment of beta 1-syntrophin sufficient to interact with translated PROTEIN1 and its homologues , suggesting that the PROTEIN binding site on PROTEIN2 occurs on a region that is conserved among the three syntrophin homologues .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN1PROTEIN2 and the PROTEIN .
0	Here , we describe the production of PROTEIN1 ( PROTEIN ) and wild-type and mutant human collagenase type I ( PROTEIN2 ) proteins in SF9 cells by the baculovirus expression system .
0	Using a protein interaction cloning technique , we identified cDNAs that encode a novel Bcl-2-binding protein , termed PROTEIN1PROTEIN2 , termed PROTEIN .
1	This demonstrates that the C-terminal hemopexin domain of PROTEIN , in contrast to the corresponding regions of PROTEIN1 and gelatinase B , does not interact with PROTEIN2 .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN1PROTEIN2 , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	Three naturally occurring ligands for the PROTEIN1 receptor ( PROTEIN ) exist : the agonists PROTEIN and PROTEIN and the PROTEIN2-receptor antagonist PROTEIN ( ref .
0	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN1PROTEIN2 ( PROTEIN ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN ) to be activated by PROTEIN , PROTEIN , and PROTEIN .
0	By rational mutagenesis , receptor-specific functional analysis , and visualization of complex formation in solution , we identified individual amino acid side chains involved specifically in the interaction of ciliary neurotrophic factor ( PROTEIN ) with CNTFR alpha and not with the beta-components , PROTEIN and PROTEIN1PROTEIN2 ( PROTEIN ) with CNTFR alpha and not with the beta-components , PROTEIN and PROTEIN .
0	We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate , namely PROTEIN1 , PROTEIN and PROTEIN versus PROTEIN2 .
0	We expressed the cDNA of human PROTEIN1 and the COOH terminus of human PROTEIN2 in reticulocyte lysates using an in vitro transcription/translation system .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN1PROTEIN2 is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	Similarly , in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase ( PROTEIN ) and phosphatase 2B [ PROTEIN ( PROTEIN ) ] are complexed by an PROTEIN1PROTEIN2 ( PROTEIN ) ] are complexed by an A kinase anchoring protein , PROTEIN .
0	This study demonstrates that PROTEIN recognizes and activates PROTEIN1 , PROTEIN , and the PROTEIN2 by distinct mechanisms .
0	Deletion analysis and binding studies demonstrate that a third enzyme , protein kinase C ( PROTEIN1 ) , binds PROTEIN at a site distinct from those bound by PROTEIN2 or PROTEIN .
0	PROTEIN1 , PROTEIN2 and PROTEIN levels were statistically greater in patients .
0	MAIN OUTCOME MEASURES : Measurement of soluble interleukin ( IL ) 2 receptor ( PROTEIN1 ) and PROTEIN2 in serum samples and fluid of recent blisters .
0	Three naturally occurring ligands for the PROTEIN1 ( PROTEIN2 ) exist : the agonists PROTEIN and PROTEIN and the PROTEIN antagonist PROTEIN ( ref .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN1PROTEIN2 and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	This work shows that single and double Ala substitutions of His18 and Phe21 in PROTEIN reduced up to 77-fold the binding affinity to PROTEIN1 ( PROTEIN ) and B ( PROTEIN ) and to the PROTEIN2 .
0	In gene transfer experiments using a human lymphoid cell line , Jurkat , coexpression of PROTEIN1 and PROTEIN provided markedly increased protection from cell death induced by several stimuli , including staurosporine , anti-Fas antibody , and cytolytic T cells , relative to cells that contained gene transfer-mediated elevations in either PROTEIN or PROTEIN2 protein alone .
0	This work shows that single and double Ala substitutions of His18 and Phe21 in PROTEIN1 reduced up to 77-fold the binding affinity to PROTEIN receptor subtypes A ( PROTEIN ) and B ( PROTEIN2 ) and to the Duffy antigen .
1	At relatively high concentrations , PROTEIN1 induced calcium mobilization and chemotaxis via PROTEIN and PROTEIN2 .
0	We propose that ( i ) the PROTEIN and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates , PROTEIN and PROTEIN , and ( ii ) PROTEIN1PROTEIN2 and PROTEIN , and ( ii ) PROTEIN interacts with the PROTEIN in a fashion that is different from that used by PROTEIN .
0	cDNA cloning and characterization of the human PROTEIN1PROTEIN2 alpha chain .
0	We propose that ( i ) the PROTEIN and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates , PROTEIN and PROTEIN1 , and ( ii ) PROTEIN interacts with the PROTEIN2 in a fashion that is different from that used by PROTEIN .
1	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN1 ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN2 and the epithelial splice form of PROTEIN ( PROTEIN ) to be activated by PROTEIN , PROTEIN , and PROTEIN .
0	The acidic amino terminus of the PROTEIN protein has been shown to contain this trans-activation activity as well as the domains for PROTEIN and adenovirus 5 PROTEIN1PROTEIN2 55-kD protein binding .
0	This work shows that single and double Ala substitutions of His18 and Phe21 in PROTEIN reduced up to 77-fold the binding affinity to PROTEIN receptor subtypes A ( PROTEIN1 ) and B ( PROTEIN2 ) and to the Duffy antigen .
1	Three naturally occurring ligands for the PROTEIN1 ( PROTEIN ) exist : the agonists PROTEIN2 and PROTEIN and the PROTEIN antagonist PROTEIN ( ref .
1	Using immunoprecipitation techniques , we have determined the rates at which PROTEIN and PROTEIN1 ( PROTEIN ) are released from PROTEIN2 in a form committed to refold to active enzyme .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN1PROTEIN2 is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	Three naturally occurring ligands for the PROTEIN receptor ( PROTEIN ) exist : the agonists PROTEIN and PROTEIN1 and the PROTEIN2 PROTEIN ( ref .
1	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the insulin-like growth factor-I receptor ( PROTEIN1 ) and the insulin receptor ( PROTEIN ) with their two known substrates PROTEIN2 and the insulin receptor substrate-1 ( PROTEIN ) .
0	Analysis of PROTEIN , PROTEIN , PROTEIN1PROTEIN2 , PROTEIN and DPC4/Smad4 .
0	Three naturally occurring ligands for the PROTEIN1 ( PROTEIN ) exist : the agonists PROTEIN and PROTEIN2 and the PROTEIN antagonist PROTEIN ( ref .
0	Three naturally occurring ligands for the PROTEIN receptor ( PROTEIN1 ) exist : the agonists PROTEIN and PROTEIN and the PROTEIN2 PROTEIN ( ref .
0	We have cloned cDNAs corresponding to the human PROTEIN1PROTEIN2 alpha chain ( PROTEIN ) .
0	Three naturally occurring ligands for the PROTEIN receptor ( PROTEIN ) exist : the agonists PROTEIN and PROTEIN and the PROTEIN1PROTEIN2 antagonist PROTEIN ( ref .
0	PROTEIN , PROTEIN1 and PROTEIN2 levels were statistically greater in patients .
0	Only weak PROTEIN binding activity was found in cells transfected with only PROTEIN1 ; however , the combination of both PROTEIN and PROTEIN2 resulted in substantial binding activity , with a Kd of approximately 400 pM , indicating that both chains are essential components of the PROTEIN receptor .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN1PROTEIN2 bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
1	Several hydrophobic amino acids in the PROTEIN1 amino-terminal domain are required for transcriptional activation , binding to PROTEIN and the adenovirus PROTEIN2 55-kD protein .
0	These mutations have no impact on the ability of the PROTEIN protein to bind to a PROTEIN1PROTEIN2 protein to bind to a p53-specific DNA element .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN1PROTEIN2 bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN ) to be activated by PROTEIN , PROTEIN1 , and PROTEIN2 .
0	Three naturally occurring ligands for the PROTEIN receptor ( PROTEIN ) exist : the agonists PROTEIN and PROTEIN and the PROTEIN1PROTEIN2 and PROTEIN and the PROTEIN antagonist PROTEIN ( ref .
1	In addition , hydrophobic residues Leu-14 and Phe-19 are crucial for the interactions between PROTEIN1 and human PROTEIN ( PROTEIN2 ) .
0	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN1 ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN ) to be activated by PROTEIN2 , PROTEIN , and PROTEIN .
0	Similarly , in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase ( PROTEIN1 ) and phosphatase 2B [ PROTEIN ( PROTEIN ) ] are complexed by an PROTEIN2 , PROTEIN .
0	Here , we describe the production of recombinant human tissue inhibitor of metalloproteinases-1 ( PROTEIN1 ) and wild-type and mutant human collagenase type I ( PROTEIN2 ) proteins in SF9 cells by the baculovirus expression system .
0	Wild-type PROTEIN , as well as the PROTEIN1 mutant lacking the C-terminal hemopexin-like domain [ des- ( 248-450 ) -MMP-1 ] , exhibit enzymatic activity upon cleavage of the prodomain by treatment with PROTEIN2 or 4-aminophenylmercuric acetate .
1	In addition , hydrophobic residues Leu-14 and Phe-19 are crucial for the interactions between PROTEIN1 and human PROTEIN2 ( PROTEIN ) .
0	RESULTS : In the blister fluid of patients with TEN , we found significantly higher levels of PROTEIN1 than in patients with burns , whereas PROTEIN2 levels were higher in the blister fluid of burned patients .
1	Taken together , PROTEIN1 is a new low-affinity functional ligand for PROTEIN , PROTEIN and PROTEIN2 , and is constitutively expressed by liver parenchymal cells .
0	We have found a COOH-terminal 37-kD fragment of PROTEIN1 sufficient to interact with translated PROTEIN and its homologues , suggesting that the PROTEIN binding site on PROTEIN2 occurs on a region that is conserved among the three syntrophin homologues .
0	In this recombinant expression system , the PROTEIN relatives , human PROTEIN1 related protein ( PROTEIN or PROTEIN2 ) and the 87K postsynaptic protein from Torpedo electric organ , also bind to translated beta 1-syntrophin .
0	Analysis of PROTEIN1 , PROTEIN , PROTEIN and PROTEIN2/Smad4 .
0	Analysis of PROTEIN , PROTEIN , PROTEIN1 and DPC4/PROTEIN2 .
0	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN1 ( PROTEIN ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN2 ) to be activated by PROTEIN , PROTEIN , and PROTEIN .
0	Only weak PROTEIN binding activity was found in cells transfected with only PROTEIN ; however , the combination of both PROTEIN1PROTEIN2 binding activity was found in cells transfected with only PROTEIN ; however , the combination of both PROTEIN and PROTEIN resulted in substantial binding activity , with a Kd of approximately 400 pM , indicating that both chains are essential components of the PROTEIN receptor .
0	The PROTEIN , PROTEIN1 , PROTEIN and PROTEIN2 genes are among those most frequently altered in pancreatic ductal carcinoma .
1	Mutant proteins were expressed in bacteria as soluble PROTEIN1 binding proteins ( PROTEIN2 ) and characterized for PROTEIN binding activity in a number of different assays .
0	Here we describe the crystal structure at 2.7 A resolution of the soluble extracellular part of type-I PROTEIN1 complexed with PROTEIN2 .
0	Rather , the hydrophobic amino acid residues Leu-22 and Trp-23 of human PROTEIN are both required for trans-activation activity , binding to the adenovirus PROTEIN1 55-kD protein and the human PROTEIN2-p53 protein in vitro .
0	Three naturally occurring ligands for the PROTEIN receptor ( PROTEIN ) exist : the agonists PROTEIN and PROTEIN and the PROTEIN1PROTEIN2 PROTEIN ( ref .
1	Evidence for a differential interaction of PROTEIN and the insulin receptor substrate-1 ( PROTEIN1 ) with the PROTEIN2 in the yeast two-hybrid system .
0	Analysis of PROTEIN1 , PROTEIN , PROTEIN and DPC4/PROTEIN2 .
0	Deletion analysis and binding studies demonstrate that a third enzyme , protein kinase C ( PROTEIN ) , binds PROTEIN1 at a site distinct from those bound by PROTEIN2 or PROTEIN .
0	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN1 ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN ) to be activated by PROTEIN , PROTEIN , and PROTEIN2 .
0	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN1 and the epithelial splice form of PROTEIN ( PROTEIN ) to be activated by PROTEIN , PROTEIN , and PROTEIN2 .
0	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN ) to be activated by PROTEIN1PROTEIN2 ( PROTEIN ) to be activated by PROTEIN , PROTEIN , and PROTEIN .
0	By rational mutagenesis , receptor-specific functional analysis , and visualization of complex formation in solution , we identified individual amino acid side chains involved specifically in the interaction of ciliary neurotrophic factor ( PROTEIN ) with CNTFR alpha and not with the beta-components , PROTEIN1 and PROTEIN2 .
0	In this recombinant expression system , the PROTEIN relatives , human PROTEIN1 ( PROTEIN or PROTEIN2 ) and the 87K postsynaptic protein from Torpedo electric organ , also bind to translated beta 1-syntrophin .
0	In this recombinant expression system , the PROTEIN relatives , human PROTEIN related protein ( PROTEIN1 or PROTEIN2 ) and the 87K postsynaptic protein from Torpedo electric organ , also bind to translated beta 1-syntrophin .
1	This work shows that single and double Ala substitutions of His18 and Phe21 in PROTEIN reduced up to 77-fold the binding affinity to PROTEIN1 receptor subtypes A ( PROTEIN ) and B ( PROTEIN ) and to the PROTEIN2 .
0	Three naturally occurring ligands for the PROTEIN1 receptor ( PROTEIN2 ) exist : the agonists PROTEIN and PROTEIN and the PROTEIN antagonist PROTEIN ( ref .
1	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the insulin-like growth factor-I receptor ( PROTEIN ) and the insulin receptor ( PROTEIN1 ) with their two known substrates PROTEIN2 and the insulin receptor substrate-1 ( PROTEIN ) .
0	Similarly , in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase ( PROTEIN1 ) and phosphatase 2B [ PROTEIN ( PROTEIN2 ) ] are complexed by an A kinase anchoring protein , PROTEIN .
1	Consistently , PROTEIN1 was found to bind to PROTEIN2 , PROTEIN and PROTEIN with relatively low affinities .
0	This study describes the distributions of bone morphogenetic protein ( BMP ) -2 as well as mRNAs for PROTEIN1PROTEIN2 as well as mRNAs for BMP receptor type IB ( PROTEIN ) .
0	Furthermore , a bacterially expressed PROTEIN fusion protein ( glutathione S-transferase-p3722W ) also activated PROTEIN1PROTEIN2 in vitro .
0	PROTEIN1 , PROTEIN and PROTEIN2 levels were statistically greater in patients .
1	Taken together , PROTEIN1 is a new low-affinity functional ligand for PROTEIN2 , PROTEIN and PROTEIN , and is constitutively expressed by liver parenchymal cells .
0	This work shows that single and double Ala substitutions of His18 and Phe21 in PROTEIN reduced up to 77-fold the binding affinity to PROTEIN1PROTEIN2 reduced up to 77-fold the binding affinity to PROTEIN receptor subtypes A ( PROTEIN ) and B ( PROTEIN ) and to the Duffy antigen .
0	We propose that ( i ) the PROTEIN and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates , PROTEIN and PROTEIN , and ( ii ) PROTEIN interacts with the PROTEIN in a fashion that is different from that used by PROTEIN1PROTEIN2 and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates , PROTEIN and PROTEIN , and ( ii ) PROTEIN interacts with the PROTEIN in a fashion that is different from that used by PROTEIN .
0	Three naturally occurring ligands for the PROTEIN1 receptor ( PROTEIN ) exist : the agonists PROTEIN and PROTEIN and the PROTEIN antagonist PROTEIN2 ( ref .
0	This work shows that single and double Ala substitutions of His18 and Phe21 in PROTEIN reduced up to 77-fold the binding affinity to PROTEIN1PROTEIN2 receptor subtypes A ( PROTEIN ) and B ( PROTEIN ) and to the Duffy antigen .
0	Similarly , in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase ( PROTEIN ) and phosphatase 2B [ PROTEIN ( PROTEIN1 ) ] are complexed by an PROTEIN2 , PROTEIN .
0	The PROTEIN1PROTEIN2 ( PROTEIN ) is a member of a family of cytokine and growth factor receptors that share conserved features in their extracellular and cytoplasmic domains .
0	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN1 and the epithelial splice form of PROTEIN ( PROTEIN ) to be activated by PROTEIN2 , PROTEIN , and PROTEIN .
1	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN1 ) to be activated by PROTEIN , PROTEIN2 , and PROTEIN .
0	These results suggest that PROTEIN1/PROTEIN2 plays a crucial role in a highly conserved mechanism for growth factor control of ras signaling .
0	By rational mutagenesis , receptor-specific functional analysis , and visualization of complex formation in solution , we identified individual amino acid side chains involved specifically in the interaction of ciliary neurotrophic factor ( PROTEIN ) with CNTFR alpha and not with the beta-components , PROTEIN and PROTEIN1PROTEIN2 and not with the beta-components , PROTEIN and PROTEIN .
0	In this recombinant expression system , the PROTEIN relatives , human PROTEIN1 ( PROTEIN2 or PROTEIN ) and the 87K postsynaptic protein from Torpedo electric organ , also bind to translated beta 1-syntrophin .
0	Single Asp or Ser substitutions , H18D , F21D , F21S , and double substitutions , H18A/F21D , H18A/F21S , and H18D/F21D , reduced up to 431-fold the binding affinity to PROTEIN1 , PROTEIN2 , and the Duffy antigen .
0	The catalytic domain of activated collagenase I ( PROTEIN ) is absolutely required for interaction with its specific inhibitor , tissue inhibitor of metalloproteinases-1 ( PROTEIN1PROTEIN2 ( PROTEIN ) .
1	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN1 is required for its association with the PROTEIN and the PROTEIN2 .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN1PROTEIN2 , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	By rational mutagenesis , receptor-specific functional analysis , and visualization of complex formation in solution , we identified individual amino acid side chains involved specifically in the interaction of ciliary neurotrophic factor ( PROTEIN ) with CNTFR alpha and not with the beta-components , PROTEIN1PROTEIN2 ) with CNTFR alpha and not with the beta-components , PROTEIN and PROTEIN .
0	This demonstrates that the C-terminal hemopexin domain of PROTEIN , in contrast to the corresponding regions of gelatinase A and gelatinase B , does not interact with PROTEIN1PROTEIN2 , in contrast to the corresponding regions of gelatinase A and gelatinase B , does not interact with PROTEIN .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN1PROTEIN2 bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	Neither mutation of His199 , nor deletion mutants des- ( 161-228 ) -MMP-1 and des- ( 161-228/248-450 ) -MMP-1 , interact with PROTEIN1PROTEIN2 and des- ( 161-228/248-450 ) -MMP-1 , interact with PROTEIN .
0	Three naturally occurring ligands for the PROTEIN receptor ( PROTEIN ) exist : the agonists PROTEIN and PROTEIN1 and the PROTEIN2 antagonist PROTEIN ( ref .
0	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the insulin-like growth factor-I receptor ( PROTEIN ) and the PROTEIN1 ( PROTEIN ) with their two known substrates PROTEIN and the PROTEIN2 substrate-1 ( PROTEIN ) .
1	Human CC chemokine liver-expressed chemokine/PROTEIN1 is a functional ligand for PROTEIN , PROTEIN and PROTEIN2 , and constitutively expressed by hepatocytes .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN1PROTEIN2 , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN1 ( PROTEIN ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN ) to be activated by PROTEIN , PROTEIN2 , and PROTEIN .
0	In this recombinant expression system , the PROTEIN relatives , human PROTEIN related protein ( PROTEIN or PROTEIN1 ) and the PROTEIN2 from Torpedo electric organ , also bind to translated beta 1-syntrophin .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN1PROTEIN2 and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	The PROTEIN1 protein shares no significant homology with PROTEIN or other PROTEIN2 family proteins , which can form homo- and heterodimers .
0	PROTEIN1 binds to an alternatively spliced exon of PROTEIN2 .
0	PROTEIN1 associates with the PROTEIN2 ( PROTEIN ) receptor after ligand stimulation , and binding of PROTEIN to this receptor promotes tyrosine phosphorylation of PROTEIN .
0	Wild-type PROTEIN , as well as the PROTEIN mutant lacking the C-terminal hemopexin-like domain [ des- ( 248-450 ) -PROTEIN1 ] , exhibit enzymatic activity upon cleavage of the prodomain by treatment with PROTEIN2 or 4-aminophenylmercuric acetate .
0	While injection of PROTEIN or PROTEIN1 proteins alone into quiescent rat fibroblasts did not have mitogenic effect , microinjection of PROTEIN2 together with PROTEIN protein stimulated DNA synthesis .
0	Consistently , PROTEIN was found to bind to PROTEIN1 , PROTEIN2 and PROTEIN with relatively low affinities .
0	Three naturally occurring ligands for the PROTEIN receptor ( PROTEIN ) exist : the agonists PROTEIN and PROTEIN and the PROTEIN1-receptor antagonist PROTEIN2 ( ref .
0	In this recombinant expression system , the PROTEIN1 relatives , human PROTEIN related protein ( PROTEIN or PROTEIN2 ) and the 87K postsynaptic protein from Torpedo electric organ , also bind to translated beta 1-syntrophin .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN1PROTEIN2 , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	Only weak PROTEIN binding activity was found in cells transfected with only PROTEIN1 ; however , the combination of both PROTEIN and PROTEIN resulted in substantial binding activity , with a Kd of approximately 400 pM , indicating that both chains are essential components of the PROTEIN2 .
0	These Ala mutants triggered neutrophil degranulation and induced calcium responses mediated by PROTEIN1 and PROTEIN2 .
1	These data indicate that Phe93 is a critical PROTEIN1 binding determinant of the PROTEIN2 .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN1PROTEIN2 and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
1	Consistently , PROTEIN1 was found to bind to PROTEIN , PROTEIN2 and PROTEIN with relatively low affinities .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN1PROTEIN2 and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	We have cloned cDNAs corresponding to the human PROTEIN1PROTEIN2 alpha chain ( PROTEIN ) .
1	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN1 is essential for the interaction with PROTEIN2 and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
1	In this recombinant expression system , the PROTEIN relatives , human PROTEIN related protein ( PROTEIN1 or PROTEIN ) and the 87K postsynaptic protein from Torpedo electric organ , also bind to translated PROTEIN2 .
0	MATERIALS AND METHODS : We measured levels of PROTEIN1 , PROTEIN , PROTEIN and PROTEIN2 in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay .
0	Three naturally occurring ligands for the PROTEIN1 receptor ( PROTEIN ) exist : the agonists PROTEIN and PROTEIN2 and the PROTEIN antagonist PROTEIN ( ref .
1	MAP kinase and the protein kinase that activates it ( PROTEIN1 ) were constitutively activated in NIH 3T3 cells infected with viruses containing either of two oncogenic forms ( p35EC12 , p3722W ) of the PROTEIN2 protein kinase .
1	We propose that ( i ) the PROTEIN and the PROTEIN1 share at least in part the same molecular mechanism underlying their interplay with their two substrates , PROTEIN2 and PROTEIN , and ( ii ) PROTEIN interacts with the PROTEIN in a fashion that is different from that used by PROTEIN .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN1PROTEIN2 is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN1 or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN ) to be activated by PROTEIN2 , PROTEIN , and PROTEIN .
0	In gene transfer experiments using a human lymphoid cell line , Jurkat , coexpression of PROTEIN1 and PROTEIN2 provided markedly increased protection from cell death induced by several stimuli , including staurosporine , anti-Fas antibody , and cytolytic T cells , relative to cells that contained gene transfer-mediated elevations in either PROTEIN or PROTEIN protein alone .
0	Evidence for a differential interaction of PROTEIN and the insulin receptor substrate-1 ( PROTEIN ) with the PROTEIN1PROTEIN2 ) with the insulin-like growth factor-I ( PROTEIN ) receptor in the yeast two-hybrid system .
0	Furthermore , a bacterially expressed PROTEIN1 fusion protein ( glutathione S-transferase-p3722W ) also activated PROTEIN2 kinase in vitro .
0	In this recombinant expression system , the PROTEIN1 relatives , human PROTEIN related protein ( PROTEIN or PROTEIN ) and the 87K postsynaptic protein from Torpedo electric organ , also bind to translated PROTEIN2 .
0	PROTEIN associates with the platelet-derived growth factor ( PROTEIN ) receptor after ligand stimulation , and binding of PROTEIN1 to this receptor promotes tyrosine phosphorylation of PROTEIN2 .
0	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the insulin-like growth factor-I receptor ( PROTEIN ) and the insulin receptor ( PROTEIN ) with their two known substrates PROTEIN and the PROTEIN1PROTEIN2 ( PROTEIN ) .
0	Analysis of PROTEIN , PROTEIN1 , PROTEIN and DPC4/PROTEIN2 .
0	Soluble PROTEIN1 receptor and PROTEIN2 in toxic epidermal necrolysis : a comparative analysis of serum and blister fluid samples .
0	This demonstrates that the C-terminal hemopexin domain of PROTEIN , in contrast to the corresponding regions of PROTEIN1PROTEIN2 , in contrast to the corresponding regions of gelatinase A and gelatinase B , does not interact with PROTEIN .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN1PROTEIN2 and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	Using PROTEIN1 as bait and supplying an exogenous tyrosine kinase gene to the yeast cells , we have found that PROTEIN interacts with another signaling protein , PROTEIN2 .
0	Only weak PROTEIN binding activity was found in cells transfected with only PROTEIN ; however , the combination of both PROTEIN1 and PROTEIN2 resulted in substantial binding activity , with a Kd of approximately 400 pM , indicating that both chains are essential components of the PROTEIN receptor .
0	While injection of PROTEIN1 or PROTEIN2 proteins alone into quiescent rat fibroblasts did not have mitogenic effect , microinjection of PROTEIN together with PROTEIN protein stimulated DNA synthesis .
0	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the insulin-like growth factor-I receptor ( PROTEIN ) and the insulin receptor ( PROTEIN ) with their two known substrates PROTEIN1 and the PROTEIN2 ( PROTEIN ) .
0	PROTEIN associates with the platelet-derived growth factor ( PROTEIN1PROTEIN2 ( PROTEIN ) receptor after ligand stimulation , and binding of PROTEIN to this receptor promotes tyrosine phosphorylation of PROTEIN .
1	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN1 is required for its association with the PROTEIN2 and the PROTEIN .
0	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN1 or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN ) to be activated by PROTEIN , PROTEIN2 , and PROTEIN .
0	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the PROTEIN1 receptor ( PROTEIN ) and the insulin receptor ( PROTEIN ) with their two known substrates PROTEIN and the PROTEIN2 ( PROTEIN ) .
0	Several hydrophobic amino acids in the PROTEIN1 amino-terminal domain are required for transcriptional activation , binding to PROTEIN and the adenovirus 5 PROTEIN2 55-kD protein .
0	Three naturally occurring ligands for the PROTEIN receptor ( PROTEIN ) exist : the agonists PROTEIN and PROTEIN and the PROTEIN1PROTEIN2 and PROTEIN and the PROTEIN antagonist PROTEIN ( ref .
0	We propose that ( i ) the PROTEIN and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates , PROTEIN and PROTEIN , and ( ii ) PROTEIN interacts with the PROTEIN1PROTEIN2 share at least in part the same molecular mechanism underlying their interplay with their two substrates , PROTEIN and PROTEIN , and ( ii ) PROTEIN interacts with the PROTEIN in a fashion that is different from that used by PROTEIN .
1	This work shows that single and double Ala substitutions of His18 and Phe21 in PROTEIN reduced up to 77-fold the binding affinity to PROTEIN1 receptor subtypes A ( PROTEIN2 ) and B ( PROTEIN ) and to the Duffy antigen .
0	We propose that ( i ) the PROTEIN and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates , PROTEIN and PROTEIN1PROTEIN2 and PROTEIN , and ( ii ) PROTEIN interacts with the PROTEIN in a fashion that is different from that used by PROTEIN .
0	In gene transfer experiments using a human lymphoid cell line , Jurkat , coexpression of PROTEIN and PROTEIN1 provided markedly increased protection from cell death induced by several stimuli , including staurosporine , anti-Fas antibody , and cytolytic T cells , relative to cells that contained gene transfer-mediated elevations in either PROTEIN or PROTEIN2 protein alone .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN1PROTEIN2 and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
1	The PROTEIN1 proteins purified from cells infected with EC12 or 22W viruses activated PROTEIN2 from skeletal muscle in vitro .
0	The findings indicate that bag-1 represents a new type of anti-cell death gene and suggest that some routes of apoptosis induction previously ascribed to PROTEIN1-independent pathways may instead reflect a need for the combination of PROTEIN and PROTEIN2 .
0	Deletion of the complete active-site [ des- ( 161-228 ) -PROTEIN1 ] within the catalytic domain , or mutation of a single His residue of the Zn2+ binding domain ( His199 ) , generates stable forms of PROTEIN proteins which are unable to digest PROTEIN2 or PROTEIN .
0	Three naturally occurring ligands for the PROTEIN receptor ( PROTEIN ) exist : the agonists PROTEIN and PROTEIN1 and the PROTEIN antagonist PROTEIN2 ( ref .
0	Deletion analysis and binding studies demonstrate that a third enzyme , protein kinase C ( PROTEIN ) , binds PROTEIN at a site distinct from those bound by PROTEIN1 or PROTEIN2 .
0	PROTEIN1 and PROTEIN2 related pathways .
1	Substitution of phenylalanine at position 93 ( Phe93 ) with alanine ( F93A mutation ) resulted in a drastic reduction in PROTEIN1 binding in the PROTEIN2 .
0	Deletion analysis and binding studies demonstrate that a third enzyme , protein kinase C ( PROTEIN ) , binds PROTEIN1PROTEIN2 ( PROTEIN ) , binds PROTEIN at a site distinct from those bound by PROTEIN or PROTEIN .
0	The catalytic domain of activated PROTEIN1 ( PROTEIN ) is absolutely required for interaction with its specific inhibitor , PROTEIN2 ( PROTEIN ) .
1	The binding of PROTEIN1 to PROTEIN2 was much less significant .
0	We also mapped the specific domains of the PROTEIN1 and PROTEIN2 participating in these interactions .
0	In this recombinant expression system , the PROTEIN1 relatives , human PROTEIN2 related protein ( PROTEIN or PROTEIN ) and the 87K postsynaptic protein from Torpedo electric organ , also bind to translated beta 1-syntrophin .
0	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the PROTEIN1 receptor ( PROTEIN ) and the insulin receptor ( PROTEIN2 ) with their two known substrates PROTEIN and the insulin receptor substrate-1 ( PROTEIN ) .
0	In this recombinant expression system , the PROTEIN relatives , human PROTEIN1 related protein ( PROTEIN or PROTEIN ) and the PROTEIN2 from Torpedo electric organ , also bind to translated beta 1-syntrophin .
0	Cloning and functional analysis of PROTEIN1 : a novel PROTEIN2 with anti-cell death activity .
0	Three naturally occurring ligands for the PROTEIN receptor ( PROTEIN ) exist : the agonists PROTEIN and PROTEIN and the PROTEIN antagonist PROTEIN1PROTEIN2 and PROTEIN and the PROTEIN antagonist PROTEIN ( ref .
1	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN1 bind to the PROTEIN2 in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	We have found a COOH-terminal 37-kD fragment of PROTEIN1 sufficient to interact with translated PROTEIN and its homologues , suggesting that the PROTEIN2 binding site on beta 1-syntrophin occurs on a region that is conserved among the three syntrophin homologues .
0	Human PROTEIN1/PROTEIN2 is a functional ligand for PROTEIN , PROTEIN and PROTEIN , and constitutively expressed by hepatocytes .
1	The PROTEIN1 receptor ( PROTEIN2 ) is a member of a family of cytokine and growth factor receptors that share conserved features in their extracellular and cytoplasmic domains .
0	Using PROTEIN1 as bait and supplying an exogenous tyrosine kinase gene to the yeast cells , we have found that PROTEIN2 interacts with another signaling protein , PROTEIN .
0	Taken together , PROTEIN is a new low-affinity functional ligand for PROTEIN , PROTEIN1PROTEIN2 , PROTEIN and PROTEIN , and is constitutively expressed by liver parenchymal cells .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN1PROTEIN2 and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	PROTEIN associates with the platelet-derived growth factor ( PROTEIN1PROTEIN2 associates with the platelet-derived growth factor ( PROTEIN ) receptor after ligand stimulation , and binding of PROTEIN to this receptor promotes tyrosine phosphorylation of PROTEIN .
0	In this recombinant expression system , the PROTEIN1 relatives , human PROTEIN related protein ( PROTEIN or PROTEIN ) and the PROTEIN2 from Torpedo electric organ , also bind to translated beta 1-syntrophin .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN1PROTEIN2 , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the PROTEIN1 receptor ( PROTEIN ) and the PROTEIN2 ( PROTEIN ) with their two known substrates PROTEIN and the insulin receptor substrate-1 ( PROTEIN ) .
0	Three naturally occurring ligands for the PROTEIN1 receptor ( PROTEIN ) exist : the agonists PROTEIN and PROTEIN and the PROTEIN2 antagonist PROTEIN ( ref .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN1PROTEIN2 is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	Residues in human leukemia inhibitory factor ( PROTEIN ) crucial for binding to both the human PROTEIN receptor ( R ) and PROTEIN were identified by analysis of alanine scanning mutants of PROTEIN1PROTEIN2 ( R ) and PROTEIN were identified by analysis of alanine scanning mutants of PROTEIN in assays for both receptor binding and bioactivity .
0	We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate , namely interleukin ( IL ) -8 , PROTEIN1 and PROTEIN versus PROTEIN2 .
0	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the PROTEIN1 ( PROTEIN2 ) and the insulin receptor ( PROTEIN ) with their two known substrates PROTEIN and the insulin receptor substrate-1 ( PROTEIN ) .
0	Soluble PROTEIN1PROTEIN2 and interleukin 1alpha in toxic epidermal necrolysis : a comparative analysis of serum and blister fluid samples .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN1PROTEIN2 , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	Three naturally occurring ligands for the PROTEIN1PROTEIN2 ( PROTEIN ) exist : the agonists PROTEIN and PROTEIN and the PROTEIN antagonist PROTEIN ( ref .
0	Similarly , in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase ( PROTEIN ) and PROTEIN1 [ PROTEIN ( PROTEIN ) ] are complexed by an A kinase anchoring protein , PROTEIN2 .
0	Analysis of PROTEIN , PROTEIN1 , PROTEIN and PROTEIN2/Smad4 .
0	Three naturally occurring ligands for the PROTEIN receptor ( PROTEIN ) exist : the agonists PROTEIN and PROTEIN1 and the PROTEIN2-receptor antagonist PROTEIN ( ref .
0	Deletion analysis and binding studies demonstrate that a third enzyme , protein kinase C ( PROTEIN ) , binds PROTEIN at a site distinct from those bound by PROTEIN1PROTEIN2 ( PROTEIN ) , binds PROTEIN at a site distinct from those bound by PROTEIN or PROTEIN .
0	A region that is important for biological function in PROTEIN , the 'receptor trigger site ' is not in direct contact with the receptor in the PROTEIN1PROTEIN2 , the 'receptor trigger site ' is not in direct contact with the receptor in the PROTEIN complex .
1	Rather , the hydrophobic amino acid residues Leu-22 and Trp-23 of human PROTEIN are both required for trans-activation activity , binding to the adenovirus PROTEIN 55-kD protein and the human PROTEIN1-PROTEIN2 protein in vitro .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN1PROTEIN2 , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	This work shows that single and double Ala substitutions of His18 and Phe21 in PROTEIN1 reduced up to 77-fold the binding affinity to PROTEIN2 receptor subtypes A ( PROTEIN ) and B ( PROTEIN ) and to the Duffy antigen .
0	Three naturally occurring ligands for the PROTEIN receptor ( PROTEIN ) exist : the agonists PROTEIN and PROTEIN and the PROTEIN1PROTEIN2 PROTEIN ( ref .
0	While injection of PROTEIN1 or PROTEIN proteins alone into quiescent rat fibroblasts did not have mitogenic effect , microinjection of PROTEIN2 together with PROTEIN protein stimulated DNA synthesis .
0	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the insulin-like growth factor-I receptor ( PROTEIN ) and the insulin receptor ( PROTEIN ) with their two known substrates PROTEIN and the PROTEIN1 substrate-1 ( PROTEIN2 ) .
0	Similarly , in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase ( PROTEIN1 ) and phosphatase 2B [ PROTEIN2 ( PROTEIN ) ] are complexed by an A kinase anchoring protein , PROTEIN .
0	Three naturally occurring ligands for the PROTEIN1 receptor ( PROTEIN ) exist : the agonists PROTEIN and PROTEIN and the PROTEIN2 PROTEIN ( ref .
0	PROTEIN1 associates with the platelet-derived growth factor ( PROTEIN ) receptor after ligand stimulation , and binding of PROTEIN to this receptor promotes tyrosine phosphorylation of PROTEIN2 .
1	We have used site-specific mutagenesis within the extracellular domain of the PROTEIN1 to search for amino acid residues involved in PROTEIN2 ( PROTEIN ) binding .
0	Taken together , PROTEIN is a new low-affinity functional ligand for PROTEIN , PROTEIN and PROTEIN1PROTEIN2 and PROTEIN , and is constitutively expressed by liver parenchymal cells .
0	Three naturally occurring ligands for the PROTEIN1 ( PROTEIN ) exist : the agonists PROTEIN and PROTEIN and the PROTEIN2 antagonist PROTEIN ( ref .
0	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN ) to be activated by PROTEIN1 , PROTEIN , and PROTEIN2 .
0	This work shows that single and double Ala substitutions of His18 and Phe21 in PROTEIN reduced up to 77-fold the binding affinity to PROTEIN receptor subtypes A ( PROTEIN ) and B ( PROTEIN1 ) and to the PROTEIN2 .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN1PROTEIN2 , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	Similarly , in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase ( PROTEIN ) and PROTEIN1 [ PROTEIN2 ( PROTEIN ) ] are complexed by an A kinase anchoring protein , PROTEIN .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN1PROTEIN2 and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
1	PROTEIN1 and the protein kinase that activates it ( PROTEIN2 ) were constitutively activated in NIH 3T3 cells infected with viruses containing either of two oncogenic forms ( p35EC12 , p3722W ) of the PROTEIN protein kinase .
0	Liver-expressed chemokine ( PROTEIN1 ) /PROTEIN2 is a human CC chemokine selectively expressed in the liver .
0	The PROTEIN protein shares no significant homology with PROTEIN1 or other PROTEIN2 family proteins , which can form homo- and heterodimers .
0	PROTEIN1 was detected in mesenchymal cells in the outer fibrous layer and chondrocytes in the inner cartilaginous matrix , positive for PROTEIN2 and Col II , respectively .
1	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN1 is essential for the interaction with PROTEIN and PROTEIN2 , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate , namely interleukin ( IL ) -8 , PROTEIN1 and PROTEIN2 versus PROTEIN .
0	Only weak PROTEIN binding activity was found in cells transfected with only PROTEIN ; however , the combination of both PROTEIN and PROTEIN resulted in substantial binding activity , with a Kd of approximately 400 pM , indicating that both chains are essential components of the PROTEIN1PROTEIN2 binding activity was found in cells transfected with only PROTEIN ; however , the combination of both PROTEIN and PROTEIN resulted in substantial binding activity , with a Kd of approximately 400 pM , indicating that both chains are essential components of the PROTEIN receptor .
0	Only weak PROTEIN binding activity was found in cells transfected with only PROTEIN1 ; however , the combination of both PROTEIN2 and PROTEIN resulted in substantial binding activity , with a Kd of approximately 400 pM , indicating that both chains are essential components of the PROTEIN receptor .
0	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the PROTEIN1 receptor ( PROTEIN ) and the insulin receptor ( PROTEIN ) with their two known substrates PROTEIN2 and the insulin receptor substrate-1 ( PROTEIN ) .
0	MATERIALS AND METHODS : We measured levels of PROTEIN1 , PROTEIN2 , PROTEIN and PROTEIN in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay .
0	We propose that ( i ) the PROTEIN and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates , PROTEIN and PROTEIN , and ( ii ) PROTEIN interacts with the PROTEIN in a fashion that is different from that used by PROTEIN1PROTEIN2 and PROTEIN , and ( ii ) PROTEIN interacts with the PROTEIN in a fashion that is different from that used by PROTEIN .
0	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN1 or PROTEIN2 and the epithelial splice form of PROTEIN ( PROTEIN ) to be activated by PROTEIN , PROTEIN , and PROTEIN .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN1PROTEIN2 , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	Using a protein interaction cloning technique , we identified cDNAs that encode a novel PROTEIN1PROTEIN2 , termed PROTEIN .
1	PROTEIN1 and the protein kinase that activates it ( MAP kinase kinase ) were constitutively activated in NIH 3T3 cells infected with viruses containing either of two oncogenic forms ( p35EC12 , p3722W ) of the PROTEIN2 protein kinase .
0	Immunoprecipitation experiments employing a polyclonal anti-PROTEIN1 antibody provided further evidence that the 60-kDa protein isolated in this study was PROTEIN2 .
0	In addition to co-immunoprecipitation analysis , we have established a rapid and sensitive ELISA assay using immobilized PROTEIN1 to determine the structural requirements of PROTEIN2 to form complexes with its inhibitor .
0	Mutant proteins were expressed in bacteria as soluble PROTEIN binding proteins ( PROTEIN1 ) and characterized for PROTEIN2 binding activity in a number of different assays .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN1PROTEIN2 is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
1	Human PROTEIN1/CCL16 is a functional ligand for PROTEIN2 , PROTEIN and PROTEIN , and constitutively expressed by hepatocytes .
0	Analysis of PROTEIN , PROTEIN , PROTEIN1 and PROTEIN2/Smad4 .
0	In this recombinant expression system , the PROTEIN relatives , human PROTEIN1 related protein ( PROTEIN or PROTEIN ) and the 87K postsynaptic protein from Torpedo electric organ , also bind to translated PROTEIN2 .
0	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the insulin-like growth factor-I receptor ( PROTEIN ) and the insulin receptor ( PROTEIN ) with their two known substrates PROTEIN1 and the PROTEIN2 substrate-1 ( PROTEIN ) .
0	Mutant proteins were expressed in bacteria as soluble PROTEIN binding proteins ( PROTEIN ) and characterized for PROTEIN1PROTEIN2 binding proteins ( PROTEIN ) and characterized for PROTEIN binding activity in a number of different assays .
1	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN1 ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN2 or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN ) to be activated by PROTEIN , PROTEIN , and PROTEIN .
1	By rational mutagenesis , receptor-specific functional analysis , and visualization of complex formation in solution , we identified individual amino acid side chains involved specifically in the interaction of PROTEIN1 ( PROTEIN ) with PROTEIN2 and not with the beta-components , PROTEIN and PROTEIN .
0	Several hydrophobic amino acids in the PROTEIN amino-terminal domain are required for transcriptional activation , binding to PROTEIN and the adenovirus 5 PROTEIN1PROTEIN2 55-kD protein .
0	MATERIALS AND METHODS : We measured levels of PROTEIN , PROTEIN , PROTEIN1 and PROTEIN2 in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay .
1	We have used site-specific mutagenesis within the extracellular domain of the PROTEIN1 to search for amino acid residues involved in PROTEIN ( PROTEIN2 ) binding .
0	The PROTEIN1 proteins purified from cells infected with EC12 or 22W viruses activated PROTEIN2 kinase from skeletal muscle in vitro .
1	The acidic amino terminus of the PROTEIN1 protein has been shown to contain this trans-activation activity as well as the domains for PROTEIN and adenovirus PROTEIN2 55-kD protein binding .
0	We have used site-specific mutagenesis within the extracellular domain of the PROTEIN to search for amino acid residues involved in PROTEIN1 ( PROTEIN2 ) binding .
1	In this recombinant expression system , the PROTEIN relatives , human PROTEIN related protein ( PROTEIN or PROTEIN ) and the PROTEIN1 from Torpedo electric organ , also bind to translated PROTEIN2 .
0	Residues in human leukemia inhibitory factor ( PROTEIN1 ) crucial for binding to both the human PROTEIN receptor ( R ) and PROTEIN were identified by analysis of alanine scanning mutants of PROTEIN2 in assays for both receptor binding and bioactivity .
0	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN1 ( PROTEIN ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN ) to be activated by PROTEIN , PROTEIN , and PROTEIN2 .
1	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the PROTEIN1 ( PROTEIN ) and the insulin receptor ( PROTEIN ) with their two known substrates PROTEIN and the insulin receptor substrate-1 ( PROTEIN2 ) .
0	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the insulin-like growth factor-I receptor ( PROTEIN ) and the PROTEIN1 ( PROTEIN2 ) with their two known substrates PROTEIN and the insulin receptor substrate-1 ( PROTEIN ) .
0	Wild-type PROTEIN , as well as the PROTEIN1 mutant lacking the C-terminal hemopexin-like domain [ des- ( 248-450 ) -PROTEIN2 ] , exhibit enzymatic activity upon cleavage of the prodomain by treatment with PROTEIN or 4-aminophenylmercuric acetate .
0	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the insulin-like growth factor-I receptor ( PROTEIN ) and the insulin receptor ( PROTEIN ) with their two known substrates PROTEIN1 and the insulin receptor substrate-1 ( PROTEIN2 ) .
0	The acidic amino terminus of the PROTEIN1 protein has been shown to contain this trans-activation activity as well as the domains for PROTEIN and adenovirus 5 PROTEIN2 55-kD protein binding .
0	Residues in human leukemia inhibitory factor ( PROTEIN ) crucial for binding to both the human PROTEIN1 ( R ) and PROTEIN2 were identified by analysis of alanine scanning mutants of PROTEIN in assays for both receptor binding and bioactivity .
0	We propose that ( i ) the PROTEIN1 and the PROTEIN2 share at least in part the same molecular mechanism underlying their interplay with their two substrates , PROTEIN and PROTEIN , and ( ii ) PROTEIN interacts with the PROTEIN in a fashion that is different from that used by PROTEIN .
1	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the insulin-like growth factor-I receptor ( PROTEIN1 ) and the insulin receptor ( PROTEIN ) with their two known substrates PROTEIN and the insulin receptor substrate-1 ( PROTEIN2 ) .
0	This demonstrates that the C-terminal hemopexin domain of PROTEIN , in contrast to the corresponding regions of gelatinase A and PROTEIN1PROTEIN2 , in contrast to the corresponding regions of gelatinase A and gelatinase B , does not interact with PROTEIN .
0	cDNA cloning and characterization of the human PROTEIN1PROTEIN2 alpha chain .
0	Inflammation , regardless of whether it is provoked by infection or by tissue damage , starts with the activation of macrophages which initiate a cascade of inflammatory responses by producing the cytokines PROTEIN ( PROTEIN1 ) and PROTEIN2 ( ref .
0	MATERIALS AND METHODS : We measured levels of PROTEIN1 , PROTEIN , PROTEIN2 and PROTEIN in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay .
0	Similarly , in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase ( PROTEIN ) and phosphatase 2B [ PROTEIN1 ( PROTEIN ) ] are complexed by an A kinase anchoring protein , PROTEIN2 .
0	This demonstrates that the C-terminal hemopexin domain of PROTEIN , in contrast to the corresponding regions of gelatinase A and PROTEIN1PROTEIN2 and gelatinase B , does not interact with PROTEIN .
1	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the PROTEIN1 ( PROTEIN ) and the insulin receptor ( PROTEIN ) with their two known substrates PROTEIN and the PROTEIN2 ( PROTEIN ) .
0	Several hydrophobic amino acids in the PROTEIN amino-terminal domain are required for transcriptional activation , binding to PROTEIN and the adenovirus 5 PROTEIN1PROTEIN2 and the adenovirus 5 PROTEIN 55-kD protein .
0	Evidence for a differential interaction of PROTEIN1 and the PROTEIN2 ( PROTEIN ) with the insulin-like growth factor-I ( PROTEIN ) receptor in the yeast two-hybrid system .
0	Single Asp or Ser substitutions , H18D , F21D , F21S , and double substitutions , H18A/F21D , H18A/F21S , and H18D/F21D , reduced up to 431-fold the binding affinity to PROTEIN1 , PROTEIN , and the PROTEIN2 .
0	Evidence for a differential interaction of PROTEIN and the insulin receptor substrate-1 ( PROTEIN ) with the PROTEIN1 ( PROTEIN2 ) receptor in the yeast two-hybrid system .
1	This demonstrates that the C-terminal hemopexin domain of PROTEIN , in contrast to the corresponding regions of gelatinase A and PROTEIN1 , does not interact with PROTEIN2 .
0	Only weak PROTEIN binding activity was found in cells transfected with only PROTEIN ; however , the combination of both PROTEIN1 and PROTEIN resulted in substantial binding activity , with a Kd of approximately 400 pM , indicating that both chains are essential components of the PROTEIN2 receptor .
0	Rather , the hydrophobic amino acid residues Leu-22 and Trp-23 of human PROTEIN are both required for trans-activation activity , binding to the adenovirus PROTEIN1 55-kD protein and the human mdm-2-PROTEIN2 protein in vitro .
0	Rather , the hydrophobic amino acid residues Leu-22 and Trp-23 of human PROTEIN1 are both required for trans-activation activity , binding to the adenovirus PROTEIN 55-kD protein and the human PROTEIN2-p53 protein in vitro .
0	The PROTEIN1 , PROTEIN , PROTEIN and PROTEIN2 genes are among those most frequently altered in pancreatic ductal carcinoma .
1	This study demonstrates that PROTEIN1 recognizes and activates PROTEIN2 , PROTEIN , and the Duffy antigen by distinct mechanisms .
0	We propose that ( i ) the PROTEIN and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates , PROTEIN and PROTEIN , and ( ii ) PROTEIN1 interacts with the PROTEIN in a fashion that is different from that used by PROTEIN2 .
0	Inflammation , regardless of whether it is provoked by infection or by tissue damage , starts with the activation of macrophages which initiate a cascade of inflammatory responses by producing the cytokines PROTEIN1 ( PROTEIN2 ) and tumour necrosis factor-alpha ( ref .
1	This study demonstrates that PROTEIN1 recognizes and activates PROTEIN , PROTEIN2 , and the Duffy antigen by distinct mechanisms .
1	In summary , we have shown that the integrity of the catalytic domain of PROTEIN1 and its ability to bind Zn2+ is absolutely required for complex formation with PROTEIN2 , which further underlines the importance of this region for proper regulation of enzymatic activity of PROTEIN .
0	PROTEIN and PROTEIN1PROTEIN2 and PROTEIN are two proteins that have critical roles in the regulation of apoptosis and the cell cycle .
0	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN1 ( PROTEIN ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN ) to be activated by PROTEIN2 , PROTEIN , and PROTEIN .
0	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN ) to be activated by PROTEIN , PROTEIN , and PROTEIN1PROTEIN2 ( PROTEIN ) to be activated by PROTEIN , PROTEIN , and PROTEIN .
0	In gene transfer experiments using a human lymphoid cell line , Jurkat , coexpression of PROTEIN and PROTEIN1 provided markedly increased protection from cell death induced by several stimuli , including staurosporine , anti-Fas antibody , and cytolytic T cells , relative to cells that contained gene transfer-mediated elevations in either PROTEIN2 or PROTEIN protein alone .
0	This study demonstrates that PROTEIN recognizes and activates PROTEIN , PROTEIN1 , and the PROTEIN2 by distinct mechanisms .
1	Using immunoprecipitation techniques , we have determined the rates at which PROTEIN1 and glutamine synthetase ( PROTEIN ) are released from PROTEIN2 in a form committed to refold to active enzyme .
0	The PROTEIN1 , PROTEIN , PROTEIN2 and PROTEIN genes are among those most frequently altered in pancreatic ductal carcinoma .
1	This study demonstrates that PROTEIN1 recognizes and activates PROTEIN , PROTEIN , and the PROTEIN2 by distinct mechanisms .
1	Furthermore , the F93A mutation in full-length PROTEIN1 expressed in COS cells abolished detectable PROTEIN2 binding .
1	PROTEIN and PROTEIN1 were chosen as substrates because they exhibit different solution requirements for the chaperonin system and they form stable `` folding arrested '' complexes with PROTEIN2 .
0	In resting human epithelial and fibroblastic cells , PROTEIN is phosphorylated on serine and threonine at five sites , three of which are phosphorylated in vitro by PROTEIN1 ( PROTEIN2 ) .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN1PROTEIN2 and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	Here , we describe the production of recombinant human tissue inhibitor of metalloproteinases-1 ( PROTEIN ) and wild-type and mutant human PROTEIN1PROTEIN2 ( PROTEIN ) and wild-type and mutant human collagenase type I ( PROTEIN ) proteins in SF9 cells by the baculovirus expression system .
0	Finally , our data highlight the crucial role of the juxtamembrane domain in signaling by both the PROTEIN and the PROTEIN1PROTEIN2 and the PROTEIN .
0	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN1 and the epithelial splice form of PROTEIN ( PROTEIN ) to be activated by PROTEIN , PROTEIN2 , and PROTEIN .
1	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the insulin-like growth factor-I receptor ( PROTEIN ) and the insulin receptor ( PROTEIN1 ) with their two known substrates PROTEIN and the insulin receptor substrate-1 ( PROTEIN2 ) .
0	Further , polyclonal antibodies to human PROTEIN significantly inhibited the mitogenic activity of PROTEIN1PROTEIN2 significantly inhibited the mitogenic activity of fibrinogen B beta chain on human fibroblasts .
0	MAIN OUTCOME MEASURES : Measurement of soluble interleukin ( IL ) 2 receptor ( PROTEIN ) and PROTEIN1PROTEIN2 ( PROTEIN ) and PROTEIN in serum samples and fluid of recent blisters .
0	Abolition of the PROTEIN1 binding site in PROTEIN created antagonists of PROTEIN2 action .
0	While injection of PROTEIN or PROTEIN proteins alone into quiescent rat fibroblasts did not have mitogenic effect , microinjection of PROTEIN together with PROTEIN1PROTEIN2 proteins alone into quiescent rat fibroblasts did not have mitogenic effect , microinjection of PROTEIN together with PROTEIN protein stimulated DNA synthesis .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN1PROTEIN2 bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	Human CC chemokine liver-expressed chemokine/CCL16 is a functional ligand for PROTEIN , PROTEIN and PROTEIN1PROTEIN2 , PROTEIN and PROTEIN , and constitutively expressed by hepatocytes .
0	Here , we describe the production of recombinant human tissue inhibitor of metalloproteinases-1 ( PROTEIN1PROTEIN2 ( PROTEIN ) and wild-type and mutant human collagenase type I ( PROTEIN ) proteins in SF9 cells by the baculovirus expression system .
0	Wild-type PROTEIN1 , as well as the PROTEIN mutant lacking the C-terminal hemopexin-like domain [ des- ( 248-450 ) -PROTEIN2 ] , exhibit enzymatic activity upon cleavage of the prodomain by treatment with PROTEIN or 4-aminophenylmercuric acetate .
0	PROTEIN associates with the PROTEIN1 ( PROTEIN ) receptor after ligand stimulation , and binding of PROTEIN2 to this receptor promotes tyrosine phosphorylation of PROTEIN .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN1PROTEIN2 and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	These findings suggest that one function of PROTEIN in mitogenic signaling is to phosphorylate and activate PROTEIN1PROTEIN2 .
0	We propose that ( i ) the PROTEIN and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates , PROTEIN and PROTEIN1 , and ( ii ) PROTEIN interacts with the PROTEIN in a fashion that is different from that used by PROTEIN2 .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN1PROTEIN2 binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the PROTEIN1 ( PROTEIN ) and the PROTEIN2 ( PROTEIN ) with their two known substrates PROTEIN and the insulin receptor substrate-1 ( PROTEIN ) .
0	Similarly , in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase ( PROTEIN ) and phosphatase 2B [ PROTEIN ( PROTEIN1PROTEIN2 [ PROTEIN ( PROTEIN ) ] are complexed by an A kinase anchoring protein , PROTEIN .
1	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN1 ) to be activated by PROTEIN2 , PROTEIN , and PROTEIN .
0	Similarly , in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase ( PROTEIN ) and phosphatase 2B [ PROTEIN ( PROTEIN1PROTEIN2 ( PROTEIN ) ] are complexed by an A kinase anchoring protein , PROTEIN .
0	At relatively high concentrations , PROTEIN induced calcium mobilization and chemotaxis via PROTEIN1 and PROTEIN2 .
0	Only weak PROTEIN binding activity was found in cells transfected with only PROTEIN1 ; however , the combination of both PROTEIN and PROTEIN resulted in substantial binding activity , with a Kd of approximately 400 pM , indicating that both chains are essential components of the PROTEIN2 receptor .
0	PROTEIN associates with the PROTEIN1PROTEIN2 ( PROTEIN ) receptor after ligand stimulation , and binding of PROTEIN to this receptor promotes tyrosine phosphorylation of PROTEIN .
0	Wild-type PROTEIN1 , as well as the PROTEIN2 mutant lacking the C-terminal hemopexin-like domain [ des- ( 248-450 ) -MMP-1 ] , exhibit enzymatic activity upon cleavage of the prodomain by treatment with PROTEIN or 4-aminophenylmercuric acetate .
0	In this recombinant expression system , the PROTEIN relatives , human PROTEIN1 related protein ( PROTEIN2 or PROTEIN ) and the 87K postsynaptic protein from Torpedo electric organ , also bind to translated beta 1-syntrophin .
0	We have localized the region of interaction to tyrosine 580 in the carboxyl end of PROTEIN1 and to the SH2 domain in the carboxy-terminus of PROTEIN2 .
1	PROTEIN1 recruitment by two distinct ligand-induced , tyrosine-phosphorylated docking sites in the PROTEIN2 intracellular domain .
0	Furthermore , a bacterially expressed PROTEIN1 fusion protein ( glutathione S-transferase-p3722W ) also activated PROTEIN2 in vitro .
0	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the PROTEIN1 receptor ( PROTEIN ) and the insulin receptor ( PROTEIN ) with their two known substrates PROTEIN and the PROTEIN2 substrate-1 ( PROTEIN ) .
0	Three naturally occurring ligands for the PROTEIN1 ( PROTEIN ) exist : the agonists PROTEIN and PROTEIN and the PROTEIN2 PROTEIN ( ref .
0	This work shows that single and double Ala substitutions of His18 and Phe21 in PROTEIN reduced up to 77-fold the binding affinity to PROTEIN receptor subtypes A ( PROTEIN1 ) and B ( PROTEIN ) and to the PROTEIN2 .
0	Consistently , PROTEIN was found to bind to PROTEIN , PROTEIN1 and PROTEIN2 with relatively low affinities .
1	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the insulin-like growth factor-I receptor ( PROTEIN ) and the PROTEIN1 ( PROTEIN ) with their two known substrates PROTEIN2 and the insulin receptor substrate-1 ( PROTEIN ) .
1	These findings suggest that one function of PROTEIN1 in mitogenic signaling is to phosphorylate and activate PROTEIN2 .
0	Single Asp or Ser substitutions , H18D , F21D , F21S , and double substitutions , H18A/F21D , H18A/F21S , and H18D/F21D , reduced up to 431-fold the binding affinity to PROTEIN , PROTEIN1 , and the PROTEIN2 .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN1PROTEIN2 and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	In TEN we also found significantly higher levels of PROTEIN1 in the blister fluid compared with serum samples , pointing to a predominantly local production contrasting with the low concentration of PROTEIN2 in the blister fluid of burned patients .
1	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the insulin-like growth factor-I receptor ( PROTEIN1 ) and the insulin receptor ( PROTEIN ) with their two known substrates PROTEIN and the PROTEIN2 ( PROTEIN ) .
1	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN1 and PROTEIN bind to the PROTEIN2 in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	We propose that ( i ) the PROTEIN and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates , PROTEIN and PROTEIN , and ( ii ) PROTEIN interacts with the PROTEIN1PROTEIN2 and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates , PROTEIN and PROTEIN , and ( ii ) PROTEIN interacts with the PROTEIN in a fashion that is different from that used by PROTEIN .
1	Using immunoprecipitation techniques , we have determined the rates at which PROTEIN and glutamine synthetase ( PROTEIN1 ) are released from PROTEIN2 in a form committed to refold to active enzyme .
1	PROTEIN1 and glutamine synthetase were chosen as substrates because they exhibit different solution requirements for the chaperonin system and they form stable `` folding arrested '' complexes with PROTEIN2 .
0	By rational mutagenesis , receptor-specific functional analysis , and visualization of complex formation in solution , we identified individual amino acid side chains involved specifically in the interaction of PROTEIN1 ( PROTEIN2 ) with CNTFR alpha and not with the beta-components , PROTEIN and PROTEIN .
0	This study demonstrates that PROTEIN recognizes and activates PROTEIN1 , PROTEIN2 , and the Duffy antigen by distinct mechanisms .
0	We propose that ( i ) the PROTEIN and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates , PROTEIN and PROTEIN , and ( ii ) PROTEIN1PROTEIN2 , and ( ii ) PROTEIN interacts with the PROTEIN in a fashion that is different from that used by PROTEIN .
0	We investigated whether the chronic inflammation and pain experienced by patients may be caused by an imbalance of proinflammatory versus anti-inflammatory cytokines within the prostate , namely interleukin ( IL ) -8 , PROTEIN and PROTEIN1 versus PROTEIN2 .
0	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the insulin-like growth factor-I receptor ( PROTEIN1 ) and the PROTEIN2 ( PROTEIN ) with their two known substrates PROTEIN and the insulin receptor substrate-1 ( PROTEIN ) .
0	While injection of PROTEIN1 or PROTEIN proteins alone into quiescent rat fibroblasts did not have mitogenic effect , microinjection of PROTEIN together with PROTEIN2 protein stimulated DNA synthesis .
0	The catalytic domain of activated collagenase I ( PROTEIN ) is absolutely required for interaction with its specific inhibitor , tissue inhibitor of metalloproteinases-1 ( PROTEIN1PROTEIN2 ( PROTEIN ) is absolutely required for interaction with its specific inhibitor , tissue inhibitor of metalloproteinases-1 ( PROTEIN ) .
0	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN1PROTEIN2 ( PROTEIN ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN ) to be activated by PROTEIN , PROTEIN , and PROTEIN .
1	PROTEIN1 also induced calcium mobilization , but marginal chemotaxis via PROTEIN2 .
0	The findings indicate that bag-1 represents a new type of anti-cell death gene and suggest that some routes of apoptosis induction previously ascribed to PROTEIN1-independent pathways may instead reflect a need for the combination of PROTEIN2 and PROTEIN .
0	Neither mutation of His199 , nor deletion mutants des- ( 161-228 ) -MMP-1 and des- ( 161-228/248-450 ) -PROTEIN1PROTEIN2 and des- ( 161-228/248-450 ) -MMP-1 , interact with PROTEIN .
0	Abolition of the PROTEIN binding site in PROTEIN1 created antagonists of PROTEIN2 action .
0	Deletion of the complete active-site [ des- ( 161-228 ) -PROTEIN1 ] within the catalytic domain , or mutation of a single His residue of the Zn2+ binding domain ( His199 ) , generates stable forms of PROTEIN proteins which are unable to digest collagen type I or PROTEIN2 .
1	We propose that ( i ) the PROTEIN1 and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates , PROTEIN2 and PROTEIN , and ( ii ) PROTEIN interacts with the PROTEIN in a fashion that is different from that used by PROTEIN .
0	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN1 ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN2 ( PROTEIN ) to be activated by PROTEIN , PROTEIN , and PROTEIN .
0	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN1 ( PROTEIN2 ) to be activated by PROTEIN , PROTEIN , and PROTEIN .
1	We propose that ( i ) the PROTEIN and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates , PROTEIN and PROTEIN , and ( ii ) PROTEIN1 interacts with the PROTEIN2 in a fashion that is different from that used by PROTEIN .
1	In spite of its binding to PROTEIN1 , PROTEIN2 was unable to inhibit infection of an R5-type HIV-1 to activated human peripheral blood mononuclear cells even at high concentrations .
1	Three naturally occurring ligands for the PROTEIN receptor ( PROTEIN ) exist : the agonists PROTEIN and PROTEIN and the PROTEIN1 antagonist PROTEIN2 ( ref .
0	Only weak PROTEIN binding activity was found in cells transfected with only PROTEIN ; however , the combination of both PROTEIN and PROTEIN1PROTEIN2 binding activity was found in cells transfected with only PROTEIN ; however , the combination of both PROTEIN and PROTEIN resulted in substantial binding activity , with a Kd of approximately 400 pM , indicating that both chains are essential components of the PROTEIN receptor .
1	Evidence for a differential interaction of PROTEIN and the PROTEIN1 ( PROTEIN ) with the PROTEIN2 in the yeast two-hybrid system .
0	We propose that ( i ) the PROTEIN and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates , PROTEIN and PROTEIN , and ( ii ) PROTEIN1PROTEIN2 and the PROTEIN share at least in part the same molecular mechanism underlying their interplay with their two substrates , PROTEIN and PROTEIN , and ( ii ) PROTEIN interacts with the PROTEIN in a fashion that is different from that used by PROTEIN .
0	By rational mutagenesis , receptor-specific functional analysis , and visualization of complex formation in solution , we identified individual amino acid side chains involved specifically in the interaction of ciliary neurotrophic factor ( PROTEIN ) with CNTFR alpha and not with the beta-components , PROTEIN1PROTEIN2 ( PROTEIN ) with CNTFR alpha and not with the beta-components , PROTEIN and PROTEIN .
0	Consistently , PROTEIN was found to bind to PROTEIN1 , PROTEIN and PROTEIN2 with relatively low affinities .
0	PROTEIN associates with the platelet-derived growth factor ( PROTEIN1 ) receptor after ligand stimulation , and binding of PROTEIN2 to this receptor promotes tyrosine phosphorylation of PROTEIN .
0	Evidence for a differential interaction of PROTEIN and the insulin receptor substrate-1 ( PROTEIN ) with the PROTEIN1PROTEIN2 ( PROTEIN ) with the insulin-like growth factor-I ( PROTEIN ) receptor in the yeast two-hybrid system .
1	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the PROTEIN1 ( PROTEIN ) and the insulin receptor ( PROTEIN ) with their two known substrates PROTEIN2 and the insulin receptor substrate-1 ( PROTEIN ) .
0	collagen types II ( Col II ) and III ( PROTEIN1PROTEIN2 ) and III ( Col III ) in a growing `` cartilage cap '' of osteochondroma .
0	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN1 and the epithelial splice form of PROTEIN ( PROTEIN2 ) to be activated by PROTEIN , PROTEIN , and PROTEIN .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN1PROTEIN2 and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
1	Consistently , PROTEIN1 was found to bind to PROTEIN , PROTEIN and PROTEIN2 with relatively low affinities .
0	Whereas PROTEIN1 serves as an alternative accessory protein to the common PROTEIN2 ( PROTEIN ) for IL-4 signaling , it could not replace the function of PROTEIN in allowing enhanced PROTEIN binding activity .
0	This study describes the distributions of bone morphogenetic protein ( BMP ) -2 as well as mRNAs for BMP receptor type IB ( PROTEIN1PROTEIN2 ( PROTEIN ) .
1	In this recombinant expression system , the PROTEIN relatives , human PROTEIN1 ( PROTEIN or PROTEIN ) and the 87K postsynaptic protein from Torpedo electric organ , also bind to translated PROTEIN2 .
0	Three naturally occurring ligands for the PROTEIN receptor ( PROTEIN ) exist : the agonists PROTEIN and PROTEIN and the PROTEIN1PROTEIN2 and PROTEIN and the PROTEIN antagonist PROTEIN ( ref .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN1PROTEIN2 is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	Similarly , in mammalian cells the cyclic adenosine 3',5'-monophosphate-dependent protein kinase ( PROTEIN ) and phosphatase 2B [ PROTEIN ( PROTEIN ) ] are complexed by an PROTEIN1PROTEIN2 [ PROTEIN ( PROTEIN ) ] are complexed by an A kinase anchoring protein , PROTEIN .
0	Three naturally occurring ligands for the PROTEIN receptor ( PROTEIN ) exist : the agonists PROTEIN and PROTEIN and the PROTEIN1PROTEIN2 ) exist : the agonists PROTEIN and PROTEIN and the PROTEIN antagonist PROTEIN ( ref .
0	These findings suggest that one function of PROTEIN1 in mitogenic signaling is to phosphorylate and activate PROTEIN2 kinase .
0	Analysis of PROTEIN , PROTEIN , PROTEIN and PROTEIN1/PROTEIN2 .
0	PROTEIN associates with the PROTEIN1 after ligand stimulation , and binding of PROTEIN2 to this receptor promotes tyrosine phosphorylation of PROTEIN .
0	In gene transfer experiments using a human lymphoid cell line , Jurkat , coexpression of PROTEIN and PROTEIN provided markedly increased protection from cell death induced by several stimuli , including staurosporine , anti-Fas antibody , and cytolytic T cells , relative to cells that contained gene transfer-mediated elevations in either PROTEIN1 or PROTEIN2 protein alone .
0	Human CC chemokine liver-expressed chemokine/CCL16 is a functional ligand for PROTEIN , PROTEIN1 and PROTEIN2 , and constitutively expressed by hepatocytes .
0	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN1 ( PROTEIN ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN2 ( PROTEIN ) to be activated by PROTEIN , PROTEIN , and PROTEIN .
0	Only weak PROTEIN binding activity was found in cells transfected with only PROTEIN ; however , the combination of both PROTEIN and PROTEIN resulted in substantial binding activity , with a Kd of approximately 400 pM , indicating that both chains are essential components of the PROTEIN1PROTEIN2 .
1	In this recombinant expression system , the PROTEIN relatives , human PROTEIN related protein ( PROTEIN or PROTEIN1 ) and the 87K postsynaptic protein from Torpedo electric organ , also bind to translated PROTEIN2 .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN1PROTEIN2 , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN1 ( PROTEIN2 ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN ) to be activated by PROTEIN , PROTEIN , and PROTEIN .
0	Superposition of the PROTEIN1 and growth hormone structures showed that the location of these epitopes on PROTEIN2 is analogous to the location of the first and second receptor epitopes on the surface of growth hormone .
0	Three naturally occurring ligands for the PROTEIN receptor ( PROTEIN1 ) exist : the agonists PROTEIN and PROTEIN and the PROTEIN antagonist PROTEIN2 ( ref .
0	We have cloned cDNAs corresponding to the human interleukin 13 receptor alpha chain ( PROTEIN1PROTEIN2 alpha chain ( PROTEIN ) .
0	The acidic amino terminus of the PROTEIN protein has been shown to contain this trans-activation activity as well as the domains for PROTEIN1 and adenovirus PROTEIN2 55-kD protein binding .
0	By rational mutagenesis , receptor-specific functional analysis , and visualization of complex formation in solution , we identified individual amino acid side chains involved specifically in the interaction of ciliary neurotrophic factor ( PROTEIN ) with CNTFR alpha and not with the beta-components , PROTEIN and PROTEIN1PROTEIN2 ) with CNTFR alpha and not with the beta-components , PROTEIN and PROTEIN .
0	Residues in human leukemia inhibitory factor ( PROTEIN ) crucial for binding to both the human PROTEIN receptor ( R ) and PROTEIN were identified by analysis of alanine scanning mutants of PROTEIN1PROTEIN2 were identified by analysis of alanine scanning mutants of PROTEIN in assays for both receptor binding and bioactivity .
0	This work shows that single and double Ala substitutions of His18 and Phe21 in PROTEIN1 reduced up to 77-fold the binding affinity to PROTEIN receptor subtypes A ( PROTEIN ) and B ( PROTEIN ) and to the PROTEIN2 .
0	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the insulin-like growth factor-I receptor ( PROTEIN ) and the insulin receptor ( PROTEIN ) with their two known substrates PROTEIN and the PROTEIN1 ( PROTEIN2 ) .
0	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the insulin-like growth factor-I receptor ( PROTEIN1 ) and the insulin receptor ( PROTEIN2 ) with their two known substrates PROTEIN and the insulin receptor substrate-1 ( PROTEIN ) .
0	Deletion analysis and binding studies demonstrate that a third enzyme , protein kinase C ( PROTEIN1 ) , binds PROTEIN2 at a site distinct from those bound by PROTEIN or PROTEIN .
0	We have cloned cDNAs corresponding to the human PROTEIN1 ( PROTEIN2 ) .
0	The findings indicate that bag-1 represents a new type of anti-cell death gene and suggest that some routes of apoptosis induction previously ascribed to Bcl-2-independent pathways may instead reflect a need for the combination of PROTEIN1 and PROTEIN2 .
0	MATERIALS AND METHODS : We measured levels of PROTEIN , PROTEIN1 , PROTEIN and PROTEIN2 in the seminal plasma of 31 patients with chronic prostatitis-chronic pelvic pain syndrome and 14 controls using enzyme-linked immunosorbent assay .
0	In summary , we have shown that the integrity of the catalytic domain of PROTEIN and its ability to bind Zn2+ is absolutely required for complex formation with PROTEIN1 , which further underlines the importance of this region for proper regulation of enzymatic activity of PROTEIN2 .
0	Only weak PROTEIN binding activity was found in cells transfected with only PROTEIN ; however , the combination of both PROTEIN and PROTEIN resulted in substantial binding activity , with a Kd of approximately 400 pM , indicating that both chains are essential components of the PROTEIN1PROTEIN2 binding activity was found in cells transfected with only PROTEIN ; however , the combination of both PROTEIN and PROTEIN resulted in substantial binding activity , with a Kd of approximately 400 pM , indicating that both chains are essential components of the PROTEIN receptor .
1	We propose that ( i ) the PROTEIN and the PROTEIN1 share at least in part the same molecular mechanism underlying their interplay with their two substrates , PROTEIN and PROTEIN2 , and ( ii ) PROTEIN interacts with the PROTEIN in a fashion that is different from that used by PROTEIN .
0	In addition , hydrophobic residues Leu-14 and Phe-19 are crucial for the interactions between PROTEIN and human PROTEIN1 ( PROTEIN2 ) .
0	We show that the S252W mutation allows the mesenchymal splice form of PROTEIN ( PROTEIN1 ) to bind and to be activated by the mesenchymally expressed ligands PROTEIN or PROTEIN and the epithelial splice form of PROTEIN ( PROTEIN ) to be activated by PROTEIN , PROTEIN2 , and PROTEIN .
0	We have cloned cDNAs corresponding to the human PROTEIN1PROTEIN2 receptor alpha chain ( PROTEIN ) .
0	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the insulin-like growth factor-I receptor ( PROTEIN ) and the insulin receptor ( PROTEIN1 ) with their two known substrates PROTEIN and the PROTEIN2 substrate-1 ( PROTEIN ) .
0	This work shows that single and double Ala substitutions of His18 and Phe21 in PROTEIN reduced up to 77-fold the binding affinity to PROTEIN receptor subtypes A ( PROTEIN1PROTEIN2 reduced up to 77-fold the binding affinity to PROTEIN receptor subtypes A ( PROTEIN ) and B ( PROTEIN ) and to the Duffy antigen .
0	Our findings can be summarized as follows : ( i ) the tyrosine kinase activity of the PROTEIN is essential for the interaction with PROTEIN and PROTEIN , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN1PROTEIN2 , ( ii ) PROTEIN and PROTEIN bind to the PROTEIN in the NPEY-juxtamembrane motif , ( iii ) contrary to PROTEIN , PROTEIN binds also to the major autophosphorylation sites ( Tyr-1131 , -1135 , and -1136 ) of the PROTEIN , and ( iv ) the amino-terminal domain of PROTEIN is required for its association with the PROTEIN and the PROTEIN .
0	PROTEIN1 ( PROTEIN2 ) /CCL16 is a human CC chemokine selectively expressed in the liver .
